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I. INTRODUCTION 
 
I.1. Infection & Immunity 
 
Host-Pathogen interactions demonstrate dynamism in evolutionary processes. Pathogens try 
to contact, colonize, infect, evade, and damage the host through many virulence factors such as 
adhesins, invasins, evasins, toxins (endotoxin/exotoxin). The host on the other hand, mobilises 
several defence mechanisms to arrest their dissemination, to prevent damage, and expel the 
invaders. Consequentially, the millions of years of reciprocity and antagonism have led both the 
systems to have highly evolved mechanisms of evasion and survival, the host with respect to its 
immune system, and the pathogen to subterfuge (Casadevall and Pirofski, 2001; Levy and Garcia-
Sastre, 2001; Ganusov et al., 2002; Roy and Kirchner, 2000; van Baalen, 1998). Innate immunity is 
an ancient defence mechanism common to both plants and animals. It serves as the first line of 
defense against external attack, that includes the recognition of pathogen associated molecular 
patterns (PAMPs) by genome encoded pattern recognition receptors (PRRs) like the Toll like 
receptors (TLRs) conserved from Drosophila to mammals. Besides, the innate system primes the 
adaptive immune sytem, which is specific to vertebrates and has the ability to adapt and remember 
the infectious pathogen. The adaptive system together with the innate system provide optimal host 
defence (Janeway, Jr. and Medzhitov, 2002; Spriggs and Sher, 1999; Ploegh, 1998). 
The immune system mounts a complicated response to infection by co-ordinating several types of 
white blood cells. The cells that govern the innate system bear the recognition receptors, which are 
germ-line encoded, in the macrophages, dendritic cells (DCs), mast cells, neutrophils, eosinophils, 
and natural killer cells (NKs). They are activated during an inflammatory response (a localised 
protective reaction of tissue to infection or injury to rapidly combat microbes) without recourse to 
adaptive immunity. Nevertheless, the stimulation of the adaptive response becomes necessary when 
the innate system is unable to deal with pathogen challenge. The innate system therefore, induces 
the expression of co-stimulatory molecules on the surface of antigen presenting cells, induces the 
secretion of appropriate cytokines and chemokines directing the lymphocytes to the appropriate 
locations in the body. Since the recognition receptors of the antigen-specific adaptive system are 
encoded in gene segments (T and B lymphocytes), there is a wide range of possible variability in 
immune recognition. However, autoimmune disease and allergy are the main disadvantages of such 
a permutation, but are normally held in check by  several layers of inhibitory mechanisms of the 
vertebrate immune system.  
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Therefore the two distinct immune mechanisms of innate and adaptive immunity work together to 
discern the pathogen, expel the pathogen, prevent self damage, and derive protection (Abbas and 
Janeway, Jr., 2000; Janeway, Jr. and Medzhitov, 2002). 
 
I.2. Cytokines as Mediators of Innate and Adaptive Immunity 
 
The stimulation of cytokine production is crucial for the development, differentiation and 
regulation of the immune response. The adaptive immune response involves humoral or circulating 
antibody (B cells) and cell mediated immunity (T cells) which identifies antigens (foreign proteins, 
polysaccharides, peptides etc.) either as part of a pathogen or as a partially degraded by-product. 
The immune system defends the body by maintaining an elaborate and dynamic communication 
network of regulatory molecules, the cytokines. The multiple functions of cytokines include 
hematopoiesis, chemotaxis, angiogenesis, embryogenesis. They play a crucial role in regulating the 
extent and the duration of the immune response by stimulating or inhibiting the activation, 
proliferation, and /or differentiation of various cells and by regulating the secretion of antibodies or 
other cytokines (Hirano, 2002; Spriggs, 1999). The cytokines of immune origin mediate and 
regulate innate immunity through the activation of type 1 interferons, tumor necrosis factor alpha 
(TNF-), interleukins IL1, IL6, IL10, IL 12, IL 15 and chemokines. They also mediate specific 
immunity through the stimulation of IL-2, IL-4, IL-5, IL-13, IL-16, IL-17, interferon- (IFN-, 
transforming growth factor (TGF-) and lymphotoxin. The cellular response to cytokines involves 
complex modulation of the immune and inflammatory responses (O’Shea et al., 2002).  
Among the heterogenous family of multifunctional cytokines, interferons were first recognised for 
their ability to induce cellular resistance to viral infection. They function by integrating early innate 
responses with later events mediated by the adaptive immune system. The IFNs are categorised into 
two distinct groups based on their protein sequences, cellular sources and the use of distinct 
receptors. Type I interferons include a number of IFN- sub-types (ten different) and a single 
species of IFN-(humans and mice), IFN-(humans) and IFN-(ruminants). They are produced 
by all cells, and predominantly by a sub-population of immature dendritic cells (DCs) during 
infections. Type II interferon contains a single member IFN-, produced by a few specialised cells 
like the activated natural killer cells (NKC), Th1 subset of the T cells, activated dendritic cells and 
macrophages. The expression of IFN- by Th1 cells is the essential bridge where the adaptive 
immune response reinforces macrophage based innate immunity (Hirano, 2002; Levy, 2002; Liew, 
2002; Spriggs, 1996; Spriggs,1999).  
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Figure 1.1 The Jak-STAT pathway of  IFN	andIFN-(Decker et al., 2002). 
The IFN-	and the FN- binding to their respective receptors activate the Jak-STAT pathway, followed by the 
translocation of the STAT homodimers, alone or with other transcription factors regulating the expression of a vast 
subset of genes. 
 
Interferons bind to specific transmembrane receptors or receptor complexes on target cells, and 
rapidly alter the pattern of gene expression as shown in figure 1.1. They exert biological activities 
by binding to their specific receptors, the type 1 receptor (IFNAR), a heterodimer comprising of 
IFNAR1 and IFNAR2 chains, and the IFN- receptor (IFNGR) forming a heterotetrameric complex 
with the two  and  chains. The receptor-ligand complex formation leads to the activation of 
cytoplasmic proteins of the Janus kinase family, Jak1 and Tyk 2 for IFN-	and Jak1 and Jak2 for 
IFN-. This allows the binding of the signal transducers and activators of transcription (STAT) to 
the receptor phosphotyrosine residues created by the kinases on the receptor, followed by 
phosphorylation, and homo- or heterodimerisation of the STATs. The STAT heterodimer is used by 
the IFN 	 pathway along with another DNA binding subunit IRF-9, forming a heterotrimeric 
transcription factor complex (ISGF3). This complex is translocated to the nucleus and binds to 
specific sites in the promoter regions, the interferon stimulated response element (ISRE) leading to 
the expression of target genes essential for innate antiviral immunity. The STAT homodimers that 
are activated by the IFN-	 or IFN- pathway, termed IFN- activating factor (GAF), recognise 
the gamma interferon associated sequence (GAS) promoter sequence, thereby regulating a vast 
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subset of genes involved in innate and adaptive immunity (Boehm et al., 1997; Aaronson and 
Horvath, 2002; Levy and Darnell, Jr., 2002; Ikeda et al., 2002; Decker et al., 2002; Ihle, 1995; Ihle, 
2001). The IFN-	 or IFN-pathways activate an overlapping set of genes via the Jak-STAT 
pathway (Levy and Garcia-Sastre, 2001; Sato et al., 2001). 
Although the cellular responses to IFN seems complex, with a regulation of several hundred genes, 
they can be described in terms of specific programmes conferring innate and adaptive resistance. 
The resistance conferred against pathogens is mediated by interactions between cells such as NK 
cells, T helper cells, cytotoxic T lymphocytes and macrophages with infected cells. Thus cytotoxic 
T lymphocytes recognise peptides derived from viral proteins when presented on the surface of 
infected cells in association with class I molecules of the major histocompatibility complex (MHC). 
This interaction leads to the lysis of the infected cell (Braciale et al.,1987, Cresswell et al., 1997). 
Macrophages phagocytose apoptotic cells by recognising ligands not present on normal cells 
(Henson et al., 2001). In contrast to the immune response based on cell-cell interactions as 
mentioned above, a cell-autonomous pathogen resistance mechanism has also been described. Such 
a resistance mechanism activated by interferons leads to intracellular pathogen inactivation, and a 
detailed account of the proteins modulating this function is discussed below. 
 
I.3. Interferon Dependent Cell Autonomous Resistance  
 
In contrast to the indirect modulation of the immune response to pathogens by interferons, e.g the 
upregulation of antigen processing and display of viral epitopes at the surface of infected cells, 
interferons can directly protect cells by inducing intracellular resistance programmes. Such IFN 
induced cell autonomous resistance involves many different programmes, functioning in different 
ways, as for example 2’-5’Oligoadenylate synthetase (OAS), PKR, NO, Nup 96/ Nup 98, Mx 
proteins (see table 1.1).  
The IFN inducible 2’-5’ Oligoadenylate synthetase (OAS) is activated by ds RNA generated during 
viral infection. Activated OAS catalyses the synthesis of 2’-5’ oligoadenylates, which binds to 
monomeric RNase L. This interaction results in the dimerisation and activation of RNase L, leading 
to the inhibition of protein expression by cleaving both the mRNA and rRNA in the cytoplasm, 
thereby arresting viral replication (Samuel, 2001). Protein kinase R is a ubiquitously expressed 
interferon inducible serine/threonine kinase. It is activated by dimerisation after binding to dsRNA. 
The eukaryotic initiation factor 2 (eIF2), one of the substrates of PKR, upon phosphorylation 
looses its activity resulting in the inhibition of protein synthesis. PKR has been demonstrated 
 to be important in the inhibition of encephalomyocarditis virus, HIV, and VSV replication 
(Williams, 2001; D'Acquisto and Ghosh, 2001). The IFN inducible Nitric oxide synthetase and its 
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product NO are known to carry out nitrosylation of viral proteins (Bogdan, 2001). NO chemically 
modifies cysteine and tyrosine residues presumably disrupting protein function (by impairment of 
folding and/or disruption of disulphide bonds within the protein). Intracellular resistance has also 
been shown in the case of nup 96/nup 98 proteins which have increased levels of expression in 
response to IFN- treatment. The vaccinia virus M protein binds to nucleoporin 96 (nup96) /nup98 
and acheives mRNA export block. It has been suggested that the increased levels of these proteins 
saturate the inhibition caused by M protein by providing enough nup98 to mediate mRNA export 
(Enninga et al., 2002). Several other IFN inducible proteins which confer intracellular pathogen 
resistance are described in the reviews (Samuel, 2001; Guidotti and Chisari, 2001) 
 
Table 1.1 Programmes of some of the IFN induced proteins conferring antiviral resistance (modified from Chesler and 
Reiss, 2002) 
 
IFN induced 
proteins 
Resistance activity Susceptible organisms 
RNaseL/ 2’-5’ OAS Inhibition of protein 
synthesis 
ECMV, HIV, Vaccinia 
PKR Inhibition of protein 
synthesis 
ECMV, HIV, VSV 
NOS Targeted nitrosylation of 
viral proteins 
VSV, HSV-1, HIV, EBV, 
Coxsakie, vaccinia virus. 
Nup96/ Nup98 reverts nuclear export block 
caused by vaccinia M protein 
Vaccinia virus 
Mx i. Prevents viral primary       
transcription 
ii. Blocks viral transport into 
the nucleus 
Wide antiviral spectrum 
for bunyavirus, thogotovirus, 
orthomyxovirus, 
paramyxovirus, rhabdovirus 
 
I.3.1. Interferon Inducible GTPases Contributing to Cell Autonomous Resistance  
There has been growing evidence for intracellular resistance provided by families of 
interferon inducible GTPases, three of those are described below. Mx GTPases are considered a 
paradigm for this mechanism where resistance is conferred by  destructively interfering with the 
life-cycle of  pathogens. 
 
 
 6
I.3.1.1 Mx GTPases 
The Mx proteins are interferon inducible large GTPases localised either in the cytosol (human MxA 
and Murine Mx2) or in the nucleus (murine Mx1). They confer viral resistance by binding to 
specific viral components. The cytosolic MxA binds to the nucleocapsids of the Thogotovirus 
(THOV) thereby preventing viral transport to the nucleus. As a consequence, the primary 
transcription that takes place in the nucleus is inhibited (Kochs and Haller, 1999). The nuclear 
mouse Mx1 protein inhibits Influenza A virus (FLUAV) and THOV multiplication also at the level 
of primary transcription of the viral genome. It is suggested that the Mx1 targets and binds the PB2 
subunit of the viral polymerase resulting in the inhibition of viral transcription (Pavlovic et al., 
1993) 
 
I.3.1.2. p65 GTPase Family/ GBPs  
The p65 family/ GBPs are highly conserved in vertebrates, in chicken, rat, mouse and man 
(Cheng et al., 1991; Strehlow et al., 1994; Asundi et al., 1994; Vestal et al., 1998, Wynn et al., 
1991; Han et al., 1998; Schwemmle et al., 1996). The family comprises four members in the Mouse 
(mGBP1, mGBP2, mGBP3, mag-2, mGBP5) (Nguyen et al., 2002) and two in Humans (hGBP1, 
hGBP2) (Neun et al., 1996) with a molecular mass of 65-71 kDa. They are induced by IFN 	 and 
strongly by IFN-(Prochazka et al., 1985). mGBPs (1-5) are absolutely dependent on the primary 
transcription factor IRF-1 (Boehm et al, 1998). They possess the canonical GTP binding motifs 
GxxxxGKS and DxxG, but instead of the (N/T)KxD motif which is believed to confer guanine 
specificity in other guanine nucleotide binding proteins (Cheng et al., 1991), they have a differently 
structured segment in which arginine and aspartic acid interact with the base through interactions 
till now unique to this GTPase family (Praefcke et al., 1999). They bind GTP, GDP and GMP with 
similar affinity, and are able to hydrolyse GTP to GMP through a trapped GDP intermediate 
(Cheng et al., 1991; Praefcke et al., 1999; Staeheli et al., 1984; Schwemmle et al., 1996). With the 
exception of mGBP3 and mag2 (Wynn et al., 1991; Han et al., 1998), all GBPs have an 
isoprenylation sequence at the C-terminus, which is functional   and  , but the 
significance of this modification is unknown since they are predominantly cytosolic (Nantais et al., 
1996). Moreover, it has been shown to be a mediator of inflammatory cytokines inhibiting 
endothelial cell growth (Guenzi et al ., 2002). mGBP2 has also been claimed to have a role in IFN-
induced murine fibroblast proliferation (Gorbacheva et al., 2002). hGBP1 is shown to be 
upregulated in mammary tumors (Sun et al., 1999) and during erythroid differentiation (Han et al., 
1998). The only evidence for cell autonomous resistance in the p65 family comes from experiments 
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with hGBP1 where it shows antiviral activity against vesicular stomatitis virus (VSV) and 
Encephalomyocarditis virus (ECMV) (Anderson et al., 1999). 
 
I.3.1.3. The p47 GTPase Family 
The p47 GTPases are encoded by 22 genes in the mouse, and represent a distinct sequence 
and structural family. They possess all the GTP binding motifs (Bourne et al., 1990; Bourne et al., 
1991), all but one of the mouse p47 genes are distributed between two clusters on chromosome 11 
and chromosome 18. The exception is mCINEMA, encoded on Chromosome 7. According to the 
remarkable substitution of a methionine for the ubiquitously conserved lysine in the GxxxxGKS 
(G1 motif)  which correlates with further features, three of the p47 GTPases define, the GMS 
subfamily (Boehm et al., 1998). The second number is given based on the order of arrangement in 
the chromosome for each sub family. An unrooted phylogeny based on the amino acid sequence is 
shown in figure 1.2.  
 
 
 
Figure 1.2. The phylogeny of the p47 GTPases (Bekpen.et al unpublished data) 
Neighbour joining tree based on distance method :- Amino:Poisson correction [pairwise distances]. It is tested using 
bootstrap test and shows high reliable branching pattern (The data not shown). Alignment of proteins was made by 
using default option of ClustalW 1.8 BCM (Baylor College of Medicine). Program used for construction of the trees 
MEGA2; Molecular 1991; Evolutionary Genetics Analysis (Kumar et al., 2001) 
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An extraordinary aspect of the phylogeny of the p47 GTPases is that this complex branching tree of 
multiple genes is (so far) present only in Murid rodents (Mouse, Rat, Hamster). In other 
mammalian groups (ungulates, carnivores, primates), only the single outlying p47 gene on mouse 
chromosome 7, mCINEMA, has a homologue, so far as is known, and this indeed a very close one 
(90,1% identity in humans). 
 
The inducibility of all the p47 members has been documented to be dependent on IFN- (Boehm et 
al., 1998), where LRG47, IRG47, TGTP/Mg21, IGTP show similar kinetics of induction (Sorace et 
al., 1995; Taylor et al., 1996). Some of them are stimulated more weakly by IFN 	and also by 
bacterial lipopolysaacharide (LPS). (Taylor et al., 1996), Lafuse et al., 1995, Sorace et al., 1995, 
Carlow et al., 1998, Zerrahn et al., 2002). IIGP induction by LPS has been shown to be dependent 
on LPS-mediated induction of type I interferon (Zerrhan et al., 2002, Lapaque et al., manuscript in 
preparation). LRG-47, IIGP, TGTP/Mg21 are also induced by graft versus host reaction (GVHR) in 
mice (Wakui et al., 2001), presumably by generalised release of interferons. p47 family members 
have generally very low constitutive levels of transcription (Boehm 1998). They are described to be 
early genes as they are transcribed independent of ongoing protein synthesis (TGTP/ Mg21, IGTP, 
LRG47 (Lafuse et al., 1995; Taylor et al., 1996). They are shown to be inducible by several cell 
types either immune or non-immune; IFN stimulated primary mouse embryonic fibroblasts, mouse 
macrophage cell line ANA-1; IIGP, GTPI, LRG47, IRG47, TGTP, IRG47 (Boehm et al., 1998), 
TGTP/Mg21 was also expressed in L-cells, fibroblasts, NIH3T3 cells, B cells, mouse peritoneal 
macrophages, macrophage cell lines (J774, P388DI, RAW 264.5 macrophages), in purified CD4+ 
CD8+ T cells, and P815 mastocytoma (Carlow et al., 1998); and IGTP in immune cells such as 
macrophages, T cells, B cells and non immune cells such as fibroblasts and hepatocytes (Taylor et 
al., 1996), Lafuse et al., 1995), IRG 47 in Pre-B and B lymphocytic cell lines (Gilly and Wall, 
1992), LRG47 in RAW 264.5 macrophages (Sorace et al., 1995). Infection seems to upregulate 
IIGP as observed in 	


	 infected bone marrow macrophages, endothelial cells, 
activated T cells (Zerrahn et al., 2002), in 

	 infected mouse liver and also in 
Scrapie infected brain tissue (Riemer et al., 2000). However, all the members are independent of the 
TNF pathway as shown by normal induction following infection of TNFRp55-/- mice with 


	 ( Boehm et al., 1998). Expression of IGTP mRNA in several mouse tissues 
revealed significant expression in the thymus and lower expression in the spleen, lung and small 
intestine; and the expression in the brain, heart, kidney, liver, skeletal muscle, and testes was very 
low or undetectable, suggesting their expression in immune cell populations (Taylor et al., 1996). 
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However, recent data from the lab show (Jia Zeng., unpublished results) IIGP1 and IGTP 
expression predominantly in the liver, and also in other tissues of wild type and IFN receptor 
deficient mice. 
 
There is irresistible evidence for the antimicrobial activity of the p47 GTPase proteins, as shown by 
infection studies in mice with targeted gene disruptions. Mice deficient in LRG47, IGTP, and 
IRG47 are highly susceptible to 	 ; LRG-47 deficient mice are additionally 
susceptible to  

	 (Collazo et al., 2001; Taylor et al., 2000). That at least a 
component of p47-mediated resistance is cell autonomous has been demonstrated for  in 
astrocytes. Astrocytes lacking IGTP cannot mount gamma-interferon-dependent resistance to 
infection with    (Halonen et al., 2001). Furthermore, cells transfected with TGTP 
showed relative resistance to plaque formation by vesicular stomatitis virus (VSV) but not herpes 
simplex virus (HSV) (Carlow et al., 1998).  
 
The strong interferon inducibility of the p47 GTPases suggests a defined adaptive function 
associated with disease resistance. How this relates to the biochemical nature of these proteins as 
GTPases is an unsolved puzzle. Generally, GTPases are proteins involved in regulating complex 
cellular processes through conformational changes associated with their nucleotide bound states, 
either GTP or GDP, defining affinities for several molecular interactions respectively, thereby 
modulating their function.  
 
I.4. GTPases, Functions and Features 
 
Many fundamental cellular processes are regulated by GTPases with a common principle of 
GTP binding and hydrolysis (Bourne, 1991). The principal action of GTPases has been studied in 
depth for p21 Ras in the control of cell growth and differentiation (Reuther, 2000), EF-Tu, EF-Ts 
for initiation, elongation and termination factors in protein synthesis (Rodnina., 2001), for G 
protein  chains in transmembrane signalling (Bourne, 1993 Hamm, 1997), for ARF GTPases in 
membrane trafficking (Donaldson, 1999) and for Ypt/Rab GTPases in vesicular targeting (Segev, 
2000). Most of the GTPases have a conserved mechanism with a cycle of GTP and GDP bound 
forms, where the exchange of GDP to GTP turns on the switch and GTP hydrolysis turns it off, 
although there are a few exceptions.  
The binding of GTP induces a change in the affinities for other macromolecules mediating key 
cellular functions. The GTPases are therefore regulated both at the level of GTP hydrolysis and at 
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the level of exchange of GDP for GTP by several other proteins. For example, GTPase activating 
proteins (GAPs) accelerate the hydrolysis of GTP and thereby turning off the GTPase switch, while 
the guanine nucleotide exchange factors (GEFs) turn on the switch by increasing the rate of GDP 
dissociation (Bourne, 1991). 
 

	










“off”
“on”


 
 
 
Figure 1.4. Simplified depiction of the GTPase cycle ( Bourne et al., 1991). 
The switch GTPases cycling between OFF and ON states. Activation requires dissociation of protien bound GDP, is 
intrinsically a slow process that is accelerated by guanine nucleotide exchange factors (GEFs). The hydrolysis of GTP 
to GDP is intrinsically very slow and thus has to be accelerated by the GTPase activating proteins (GAPs). 
 
The GTPase cycle in some small GTPases like Rho, and Rabs is also regulated by guanine 
nucleotide dissociation inhibitors (GDIs). GDI is specifically a protein inhibitor of the Rab and Rho 
GTPases which prevents GDP dissociation, and escorts the GTPase in the cytosol, until it reaches 
the membrane where it is activated (Wu et al., 1996). In addition, another regulatory molecule 
called the GDI displacement factor (GDF) is active on a subset of Rab proteins and is devoid of 
exchange activity (Olofsson, Novick). 
 
I.4.1. Characteristic Features of the GTPase domain (G domain) 
The G domain is highly conserved in all guanine nucleotide binding proteins. The conserved 
G domain has a typical fold consisting of a mixed six-stranded  sheet and five helices. The 
GTPases have canonical GTP binding sequence elements which constitute the nucleotide binding 
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site. The most important contributions to nucleotide binding is made by the G1 motif, designated as 
the phosphate binding loop (p-loop) which interacts with the andphosphates, the N/TKxD 
sequence (G3 motif) contacts the nucleotide base. The specificity to guanine is derived by the Asp 
side chain from the G4 motif, DxxG, which forms a hydrogen bond with the base, and also a main 
chain interaction with the invariant Ala from the G5 motif (SAK). The nucleotide bound form 
stabilises two flexible regions termed the switch regions. switch I (forming the G2 motif) 
comprising the invariant threonine and the switch II (comprising the G4 motif) with the invariant 
glycine interacting with the  phosphate.  
All the members of the heterotrimeric G proteins, several Ras related proteins like Ras, Rab, Ral, 
Rac, rho, Cdc42, Arf, Arl, Rab, Ran have the canonical GTP binding motifs as well as the 
conserved fold for the G domain. The G domains of the signal recognition particle SRP and its 
receptor SR show a divergent topology of the sheet, in addition to extensions and insertions. 
Tubulin and the bacterial homologue FtsZ deviate structurally from these proteins with respect to 
their G domain.  
The switch regions are not only conserved in GTPases, but also within the family of ATP-binding 
motor proteins. Kinesin and myosin have switch regions which sense the presence of a phosphate, 
the release of which is coupled to production of  mechanical energy. The switch I region here 
contains a conserved serine and the switch II region comprises the same DxxG motif with an 
invariant glycine forming a main chain contact to the phosphate. 
 
I.4.2. Deviation from the Switch GTPases 
The GTP bound form is critical for transducing downstream cellular functions among many 
GTP binding proteins. The large GTPase dynamin participates in clathrin mediated endocytic 
processes and endocytosis via caveolae. The fact that the large GTPase dynamin could sever 
clathrin coated vesicles from plasma membrane upon GTP hydrolysis started a debate on the 
functioning of dynamin. Whether dynamin is a mechanochemical enzyme using the energy of 
hydrolysis for its effector function or a switch GTPase using the time from GTP binding to GTP 
hydrolysis for signal transduction? The switch GTPases have a very high affinity for GTP, a very 
slow rate of GTP hydrolysis and do not release GDP easily. In contrast mechanoenzymes such as 
dynein, kinesin and myosin have a low affinity for ATP, a high rate of ATP hydrolysis and readily 
release ADP. Dynamin like most motor proteins is a large protein, around 100 kDa, has low affinity 
for nucleotides, high rate of GTP hydrolysis and readily releases the hydrolyzed nucleotide. In 
addition, like muscle myosins and flagellar dyneins, dynamins assemble into complex polymers. 
Consistently, it has been shown that GTP binding alone is insufficient to support endocytosis, but 
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GTP hydrolysis which allows for a conformational change in the protein is necessary. The carboxy 
terminus of dynamin contains a proline rich domain (PRD) that extends to interact with SH3 
domain containing proteins which implicates dynamin in signalling (Schmid et al., 1998). Up to 
now, dynamins have been shown to participate in both cell signalling and vesicle formation 
(sweitzer et al., 1998; zhang et al ., 2001) through  “effector binding” and “constriction of the 
membrane” respectively.  
The prime objective of the work is to understand the GTPase functions of the IFN inducible p47 
GTPases, and how they exercise their resistance function. 
 
I.5. Objective of this Work 
 
IFNs promote protection of the host by activating the Jak-STAT pathway to mediate rapid 
transcriptional induction of several hundred genes. Deletion of any of the components of this 
system highlights their importance for the proper functioning of the immune system. Since, many 
genes are induced or repressed by IFNs, and the functional roles of only a few have been described, 
it seems plausible that there are many more mechanisms to be unravelled in order to understand the 
complex cellular response in full. For example although mice deficient for the three-major IFN 
mediated antiviral pathways, PKR, RNase L and Mx were indeed sensitive to viral infection, were 
nevertheless able to mount a measurable antiviral response after IFN treatment and show greater 
resistance to infection than mice lacking IFN 	receptors or Stat1 (Zhou et al., 1999). This 
provides clear evidence for the existence of other uncharacterized interferon-dependent pathways. 
Therefore it seems important to look at the functions of other IFN induced genes, to understand the 
complex cellular response of this cytokine.  
The p47 family and the p65 family of GTPases are abundantly induced by IFNs, and since their 
presence is necessary for the survival of the individual (not shown for p65), they probably have a 
defined role in the IFN response against specific pathogens. Localisation studies reveal the 
association of the p47 GTPases with the intracellular membranes (Sascha Martens unpublished 
data, Zerrahn et al., 2002, Taylor et al., 1997) suggesting their role in the processing of proteins or 
lipids, or in the vesicular trafficking pathway. It is a hypothesis that IIGP1 might be protecting the 
cell by interfering with the life cycle of specific pathogens. By doing so, it probably prevents the 
exploitation of the ER/Golgi membrane by the pathogens. 
The objective of this study is to contribute to an understanding of the function of the p47 family of 
GTPases, specifically of IIGP1, by analysis of the biochemical properties and structure. This will 
provide essential information to understand the function and mechanism of action of IIGP-1 and 
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other p47 GTPases in cells. The p47 GTPases are apparently present only in the Muridae, yet 
understanding the mechanism of action of these GTPases could, firstly, help us in understanding the 
whole spectrum of the IFN response. Secondly, they may help us to identify the systems that 
compensate for the absence of the p47 family in humans. Thirdly, they will help us to describe the 
uniqueness of the immune system in different organisms. Finally, we will gain insight into an 
aspect of pathogen vulnerability that is not apparent from human  systems.  
The work presented here attempts to understand the functioning of IIGP1. The first part of the work 
emphasizes the GTPase properties of IIGP1 by  biochemical characterization. A detailed 
analysis of the nucleotide binding affinities of IIGP1, the kinetics of the binding reaction, and the 
kinetics of GTP hydrolysis have been investigated using various biochemical and biophysical 
methods. This part also describes cellular studies of IIGP1, concerning its location and distribution 
in the cell, and preliminary studies to identify interacting molecules. The second part describes the 
structure of IIGP1 and a programme of site-dircted mutagenesis directed at the nucleotide binding 
site and residues involved in putative homotypic molecular interactions, and their   and 
 characterisation.  
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II. MATERIALS AND METHODS 

II.1. Chemicals and Other Accessories 
All chemicals were purchased from Aldrich (Steinheim), Amersham-Pharmacia (Freiburg), 
Applichem (Darmstadt), Baker (Deventer, Netherlands), Boehringer Mannheim (Mannheim), Fluka 
(Neu-Ulm), GERBU (Gaiberg), Merck (Darmstadt), Pharma-Waldhof (Düsseldorf), Qiagen 
(Hilden), Riedel-de-Haen (Seelze), Roth (Karlsruhe), Serva (Heidelberg), Sigma-Aldrich 
(Deisenhofen), ICN biochemicals, Oxoid, Hampshire UK, DNA standard markers from Gibco-BRL 
(Eggenstein), Agarose for gel electrophoresis from FMC, Bioproducts, Rockland, Maine USA, 
developing and fixing solution for western blot detection from G158, AGFA,  Luminol (Sigma),  P-
coumaric acid from Fluka. Deionised and sterile water  (seral TM) was used for all the buffers and 
solutions, Ultra pure water derived from Beta 75/delta UV/UF from USF Seral reinstwassersysteme 
GmbH, Ransbach, Baumbach equipped with UV (185/254nm) and ultrafiltration (5000 kd cut off). 
pH values are adjusted for room temperature unless specified. 
 
II.2. Materials 
Sterilefilter FP 030/3 0,2 m and ME 24 0,2 m (Schleicher and Schüll, Dassel) 
Ultrafiltration device VIVASPIN 10, 30 (Vivascience (Lincoln, USA) 
Nitrocellulose transfer membrane PROTRAN (Schleicher and schüll, Dassel) 
3MM Whatmann paper (Sigma) 
100 Sterican 0,50 x 16mm hypodermic needles(B/Braun, Melsungen AG)  
0.2µM and 0.45µM sterile filters (schleicher and schuell) 
Superdex 200 (Amersham Pharmacia, Freiburg) 
GSH-Sepharose superflow (Amersham Pharmacia, Freiburg)  
Protein A Sepharose CL4B (Amersham Phamacia, Freiburg) 
Film, X-OMAT LS and AR, Kodak, Sigma 
All plastic ware for cell culture was from Sarstedt, Nümbrecht and Greiner, Solingen  
 
II.3. Enzymes/Proteins 
Restriction Enzymes from New England Biolabs (Bad Schwalbach) or Clonetech (Heidelberg) 
Protease Inhibitor cocktail, Complete mini (Böhringer), Pefabloc (Roth) 
Pyrococcus furiosus (Pfu) DNA  Polymerase (Promega, Mannheim) 
T4 DNA polymerase (New England Biolabs ) 
RNase A (Sigma) 
Shrimp Alkaline Phosphatase (SAP),USB, Amersham) 
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Thrombin (Serva, Heidelberg) 
1Kb ladder for Agarose gels (Gibco) 
Rainbow –Molecular weight marker-Precision protein standardsTM( Biorad) 
SDS-7 Protein Standard Marker 14.2; 20; 24; 29; 36; 45 and 66 kDa (Sigma, Diesenhofen) 
SDS-6 protein standard marker 29; 45; 66; 97.4; 116 and 205 kDa  (Sigma, Diesenhofen) 
 
II.4. Reagent Kits 
Plasmid Mini and Midi kit (Qiagen ,Hilden) 


 (Qiagen, Hilden) 




 (ABI PRISM) 
QuikChange TM 




		 
 
II.5. Vectors 
PGW1H ( British Biotech, Oxford, England) 
pGEX-4T-2 (Amersham Pharmacia, Freiburg) 
 
II.6. Oligonucleotides 
All oligonucleotides from Sigma ARK. They are supplied as powder and are resuspended to a final 
concentration of 10 nMoles. 1 µl used for each PCR reaction. 
GTPI-3’       CCCCCCCCGAATTCCATGGAAGAGGCAGTTGAGTCA 
GTPI-5’       CCCCCCCCGAATTCCTAATGATGATGATGATGATGAGGA 
                     TGAGGAATGGAGAGTC 
L44R-s        CTCAATTTGATTGAAAGAAGGATGAGAAAAGGG 
L44R-As     CCCTTTTCTCATCCTTCTTTCAATCAAATTGAG 
K48E-s       GAATTAAGGATGAGAGAAGGGAATATTC AGTTG  
K48E-As    CAACTGAATATTCCCTTCTCTCATCCTTAATTC 
K48A-s       GAATTAAGGATGAGAGCAGGGAATATTCAGTTG  
K48A-As    CAACTGAATA TTCCCTGCTCTCATCCTTAATTC 
S172R-s      ATTGCCAAAGCAATCAGAATGATG AAGAAGGAA  
S172R-As   TTCCTTCTTCATCATTCTGATTGCTTTGGCAAT 
M173A-s    ATTGCCAAAGCAATCAGCGCTATGAAGAAGGAATTCTAC  
M173A-As GTAGAATTCCTTCTTCATAGCGCTGATTGCTTTGGCAAT  
K82A-s      GAGACGGGATCAGGGGCTTCCAGCTTCATCAAT 
K82A.-As   ATTGATGAAGCTGGAAGCCCCTGATCCCGTCTC 
 
 17
D186N-s     GTGAGAACCAAGGTGAATTCTGACATAACAAAT 
D186N-As  ATTTGTTATGTCAGAGTTCACCTTGGTTCTCAC 
 
II.7. Constructs 
II. 7.1. pGEX Constructs 
II.7.1.1. pGEX p47 Constructs 
 
	 
 
  
  
  
  
IGTP 
 
 
LRG-47  
 
II.7.1.2. pGEX IIGP1 Constructs 
 
 
	 
 
 


 



 
(Interface mutants 
as well as binding 
mutants) 




 
a) Interface I mutants:- L44R, K48A, K48E;  b) Interface II mutants :- S172R, M173A;  
c) Double mutant :- L44R/S172R [L/S]; d) Binding mutants :- G2V, K82A, D186N. 
II.7.2. pGW1H Constructs 
 
	 
 
  

  

 A 

  

  

 
a) Interface I mutants:- L44R, K48A, K48E;  b) Interface II mutants :- S172R, M173A 
c) Double mutant :- L44R/S172R [L/S];  d) Binding mutants :- G2V, K82A 
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II.8. Media 
Luria Bertini (LB)- Medium 
10 g Bacto Tryptone 
5 g Yeast Extract 
10 g Nacl 
Distilled water 1Litre 
 
LB Plate Medium 
10 g Bacto Tryptone 
5 g Yeast Extract 
10 g Nacl 
15 g Bacto Agar 
Distilled water 1Litre 
 
Terrific Broth (TB) Medium 
12 g Bacto Tryptone 
24 g Yeast Extract 
4 ml Glycerol 
0.17 mM KH2PO4 
0.072 mM K2HPO4 
Distilled water 1 Litre 
 
IMDM (Iscove’s Modified Dulbecco’s Medium)  Gibco BRL, Eggelstein. 
10% FCS, 2 mM 1-Glutamine, 1 mM Sodium pyruvate, 100 U/ml Penicillin,100 µg/ml 
Streptomycin, 1x non-essential amino acids. (mainly used for the growth of L929 cells). 
 
DMEM (Dulbecoo’s Modified Eagle Medium), Gibco BRL,Eggenstein. 
10% FCS, 2 mM 1-Glutamine, 1 mM Sodium pyruvate, 100 U/ml Penicillin,100 µg/ml 
Streptomycin, 1x non-essential amino acids. (mainly used for the growth of MEFs). 
 
DMEM (Dulbecoo’s Modified Eagle Medium)- Starvation Medium 
1x, 0.1 µ filtered, with high glucose and pyridoxine hydrochloride, without sodium pyruvate, L-
cystine and L-methionine. FCS was dialysed against 1x PBS overnight at 4°C and was added to the 
medium, also pyruvate and L-glutamine. 
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II.9. Bacterial Strains  
XL1-Blue - recA1, end A1, gyrA96, thi-1, hsdR17, supE44, relA1, lac, [F’, , qZ
 !", 
Tn!# (Tetr)], (Bullock 
.,379) 
 
DH5- $#%recA1, endA1, gyrA96, thi-1, hsdR17 (rB-, mB+), supE44, relA1, deoR, 
&%'()U169; Bachmann (1983,1990), Sambrook J.et al.(1989). 
BL-21 -  * B, F-, omp T, hsd S (rB- mB-), gal, dcm (Studier 
 ,1986) 
 
II.10. Antibiotics 
Ampicillin (Sigma) was prepared as a stock solution of 100 mg/ml in water.  
kanamycin (Sigma) stock solution was made as 10 mg/ml in water. 
Penicillin/Streptomycin (Gibco BRL, Eggenstein) 
 
II.11. Cells 
Mouse embryonic fibroblasts (MEFs) 
L929 cells (Mouse fibroblast cell line) 
 
II.12. Radiisotope 
PRO-MIX L- [35S ]  Cell Labelling Mix (Amersham-Pharmacia, Freiburg), 
 
II.13. Antibodies 
IgG anti-Mouse peroxidase coupled (Sigma),  
IgG anti-Rabbit peroxidase coupled (Sigma) 
Second stage antibodies were goat anti-mouse Alexa 546, 1:100 (Molecular Probes), Goat anti-
rabbit Alexa 546, 1:1000 (Molecular Probes). 
10D7, 10E7 and 5D9 monoclonal antibodies (Zerrahn 
 ) 
 
II.14. Detergents  
 3[(3-Cholamindopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), Triton-X-100 (Tx-100), 
Polyoxyethylensorbitanmonolaureat (Tween-20), Triton-X-114 (Tx 114), Thesit , IGEPAL-CA 600 
(NP-40) all from Sigma. Digitonin (Wako), sodium dodecyl sulfate (SDS) Merck, Darmstadt. 
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II.15. Equipments 
Centrifuges-Biofuge 13, Heraeus, Sigma 204, Sigma 3K10, Labofuge 400R, heraeus; Sorvall RC-
5B, Du pont instruments, Optima TLX Ultracentrifuge, Beckmann, BioRAD Gel dryer, Model-583, 
BioRad Power pack 300bzw. 3000, gel electrophoresis chamber, Cambridge electrophoresis 
limited, Biorad Mini Protean II, PTC-100,MJ Research,Inc; Centrifuge tubes 15ml, TPP, 
Switzerland; 50ml Falcon, Becton Dickenson, USA.Soft-Pac TM Module, Du R Spectrophotometer.  
 
II.16. Protocols 
 
II.16.1. !	! "!#$

All the constructs mentioned above were amplified/ cloned and propagated using the following 
methods. All protocols were adapted from Sambrook, J., Fritsch, E.F., and Maniatis, T., Vol. 1,2,3 
(1989), or from the cited references. 
 
II.16.1.1. Agarose Gel Electrophoresis 
DNA was evaluated by agarose gel electrophoresis where the negatively charged DNA 
fragments migrate through polymerised agarose (0.9%) towards the anode, by applying electric 
current (less than 5 volts per centimeter of the gel) in a buffer that establishes a pH and provides 
ions for conductivity (1x TAE; 0.04 M Tris, 0.5 mM EDTA, pH adjusted to 7.5 with acetic acid) 
and the DNA was stained with Ethidium bromide (0.5 µg/ml), a fluorescent dye which intercalates 
between nucleotide bases, and the migration of the DNA molecules was recognised by using 
bromophenol blue as tracking dye (Studier, 1973)  
 
II.16.1.2. Polymerase Chain Reaction (PCR)  
The selective amplification of specific DNA fragments from vectors for cloning was made 
by PCR using pfu polymerase, a thermostable DNA polymerase and two specific primers (Mullis 
and Faloona, 1987). The plasmid pGW1H with the 1.2 Kb insert for GTPI was resuspended in 10 
mM Tris/Hcl pH 8.0. Only 1µl (1 ng) of the template, 5U polymerase; 1x PCR buffer, 5 pmol each 
of the 5’ and the 3’primer, 0.2 mM dNTPs was added, and made to a final volume of 50 µl. The 
PCR conditions were 1’, 95°C; 35x (30’’, 95°C; 30’’ 62°C; 1’, 72°C); 2’, 72°C;  4°C). the 
annealing temperature was calculated as 2 x (AT) + 4 x (GC).  
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II.16.1.3. Restriction Enzyme Digestion 
The DNA to be cloned into a vector (insert DNA) and the vector DNA to be cloned into, 
was independently restricted with the respective enzymes to make the compatible termini with 5’ 
phosphate residues and 3’ hydroxyl moieties. All constructs were made by cloning the Sal1 
fragments of all the p47 GTPases mentioned above into a Sal1 restricted  pGEX / pGW1H vector. 
5-10 U of enzyme was used per g of DNA, 1x adequate buffer for the enzyme, 1x BSA was used 
when suggested for the respective enzyme, in a final volume of 20 l / g of DNA and incubated at 
37°C for 1 hour (Luria, 1970).  
 
II.16.1.4. Purification of DNA Fragments 
The specific size of the restricted DNA to be cloned, was cut and purified from the agarose 
gels after adequate separation. The purification was done based on the high pure PCR/ gel 
purification kit. The gel fragment is dissolved in 3 M guanidine-thiocyanate,10 mM Tris-Hcl, 5% 
ethanol (v/v) pH 6.6 at 50°C for 15-20 min, and then adsorbed onto glass fibres, washed with 20 
mM NaCl, 2 mM Tris-HCl, pH 7.5, 5% ethanol, to remove salts, free-nucleotides (below 100 bp) 
and proteins. Finally the DNA is eluted with a low salt buffer 10 mM Tris-HCl, 1 mM EDTA, pH 
8.5. (The initial experiments regarding the purification of DNA is well described in (Brownlee and 
Sanger, 1969; Carter and Milton, 1993) 
 
II.16.1.5. Ligation  
1: 3 molar ratio of linearised vector prior dephosphorylation (pM) as opposed to insert DNA 
(purified), T4 DNA ligase ( 1U), 1x DNA ligase buffer in a final volume of 10 µl, and incubated 
overnight at 16°C (Bercovich et al., 1992; Michelsen, 1995). De-phosphorylation was done on the 
linearised vector to prevent intramolecular ligation. The linearised vector was incubated at 65°C for 
20 min to inactivate the restriction enzyme, shrimp alkaline phosphatase (.1U/ µg DNA), incubated 
for 1h at 37°C, and inactivated at 65°C for 20 min. The dephosphorylated DNA was purified as 
described above.  
 
II.16.1.6. Preparation of Competent Cells 
A single colony from a particular strain of * (DH5 and BL-21) was grown overnight 
in 2 ml LB medium with 0.02 M MgSO4, 0.01 M KCl with vigorous shaking (~300 rpm). It was 
diluted 1:10 into fresh medium with the same constituents for an hour and a half, at 37°C to an 
OD600 of 0.45, on ice for 10 min after which the cells were resuspended by spinning at 6000 rpm, 
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4°C for 5’ in an centrifuge which was prior cooled to 4°C. The cells were resuspended in TFB I (30 
ml/100 ml culture), 5 min on ice, cells pelleted again by centrifugation at 6000 rpm, 4°C for 5’, 
resuspended in TFB II (4 ml /100 ml culture). 100 µl aliquots of the competent bacteria were made 
and were frozen in –80°C (Chung and Miller, 1988).  
Composition of the buffers:- TFB I (30 mM potassium acetate, 50 mM MnCl2, 100 mM RbCl2, 10 
mM CaCl2, 15% w/v glycerin, pH 5.8;  TFBII (10 mM  Mops, pH 7.5, 75 mM CaCl2, 100 mM 
RbCl2, 15% w/v glycerin. Both the solutions were sterilised and stored at 4°C. DH5was used for 
the maintenance of the plasmids and BL-21 cells for protein expression) 
 
II.16.1.7. Transformation 
Competent bacteria (100 µl) were thawed in ice, the ligation mix was added to the 
competent bacteria and incubated on ice for 30 min, heat-shock was given at 42°C for 90 sec, 1 ml 
of LB medium added and incubated at 37°C in a Rotator for an hour. The bacteria were pelleted by 
centrifuging at 8000 rpm for 1 min, resuspended in 100 µl medium and plated in LB agar plates 
with Ampicillin (1 mg/ml) (Cohen et al., 1972). 
 
II.16.1.8. Plasmid DNA Isolation 
The plasmid DNA was prepared using the Qiagen midi-prep protocol. A single colony was 
inoculated into LB medium with Ampicillin (1 mg/ml) was grown overnight with vigorous shaking 
(~300 rpm) at 37°C, 1:10 diluted into fresh LB/Ampicillin medium and grown overnight (100 ml 
culture). The cells were pelleted , and resuspended in 50 mM Tris, pH 8.0, 10 mM EDTA, 100 
µg/ml RNase A; and were lysed with 200 mM NaoH (denatures proteins, plasmid and chromosomal 
DNA), 1% SDS (solubilises phospholipid and protein constituents of the cell membrane (Birnboim 
and Doly, 1979), The RNA was cleaved by RNase A during this alkaline lysis, and the lysate was 
neutralised by adding 3M potassium acetate pH 5.5, which leads to salt detergent complexes as 
SDS precipitates and all the cellular debris, chromosomal DNA and denatured proteins settle down, 
leaving the plasmid DNA in the supernatent. The whole lysate mix was then passed through 
Qiafilter cartridges which further remove all the debris, and the supernatent was selectively bound 
to the Qiagen anion exchange resin where the negatively charged phosphates in DNA bind to the 
DEAE (Dietheylaminoethanol) groups on the surface of the resin (silica beads). All the impurities 
are further removed upon washing the resin with a medium salt buffer like 1M NaCl, 50 mM 
MOPS, pH 7.0, 15% isopropanol and finally the bound plasmid was eluted with the high salt buffer 
1.25M NaCl, 50 mM MOPS, pH 8.5, 15% isopropanol.  
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The eluted DNA was desalted and concentrated by isopropanol precipitation at RT, and the 
DNA pellet was further washed with 70% ethanol, as it is more volatile and to remove the 
remaining salt, the pellet was air-dried and resuspended in a small volume of Tris / EDTA pH 8.0. 
All the plasmids and constructs were prepared using this method, and were used for transfection 
studies, and sequencing studies. 
 
II.16.1.9. Determination of the Concentration of DNA 
The concentration of DNA was measured using a spectrophotometer at 260 nm. The purity 
of the DNA solution was estimated using the ratio of OD readings at 260 nm and 280 nm, where 
pure preparations of DNA have an OD260/OD280 ratio of 1.8. The concentration was calculated 
according to the following equation (Glasel, 1995). c = A260 x 50 µg/ml x dilution factor 
 
II.16.1.10. Site Directed Mutagenesis  
Site directed mutagenesis was carried out using the using the  “QuikChangeTM XL Site-
Directed Mutagenesis” protocol from Stratagene. PCR was carried out using pGEX-IIGP1 as the 
template, the two respective oligonucleotide primers (sense and antisense) for each of the mutants, 
each primer complementary to opposite strands of the vector. Therefore new strands synthesised 
during temperature cycling by Pfu polymerase (Stratagene), under these conditions ; denaturing 
temperature of  95°C for 30s, annealing temperature of 55°C for 60s and an extension with 72°C for 
13min involving 15 cycles. The PCR product was then digested with Dpn1 enzyme (10U) at 37°C 
for 1 hour. Since Dpn1 restricts methylated and hemi-methylated DNA, only the newly synthesized 
DNA with the mutations are selected,  and they are transformed into BL-21 competent cells 
(Wilkinson et al., 1983; Winter et al., 1982). 
 
II.16.1.11. DNA Sequencing 
All the plasmid DNA was sequenced using the  +	R ,
TM Terminator Cycle 
Sequencing Ready Reaction Kit (PE Applied Biosystems), using fluorescently labelled 
dideoxynucleotides based on the dideoxy-chain termination method by Sanger et al 1977 (Lee et 
al., 1992). DNA sequencing was done for the analysis of all the plasmid constructs and also the 
mutants. DNA (0.5 g), respective primer (5 pmole), 2 µl (,
TM terminator ready reaction mix 
from ABI), in a total volume of 10 µl. Sequencing reaction was carried out (5’, 96°C; 25x (30’’, 
96°C; 15’’ 50°C; 4’, 60°C); 4°C, infinity)). The annealing temperature was calculated using the 
equation  2x (AT) + 4x (GC). 
The DNA was precipitated with 1/10th volume 3M sodium acetate and 2 volumes of 100 % ethanol 
(Maniatis 
. 1989), -20°C for 30 min, centrifuged at 10,000 rpm, 4°C, 15 min, 70 % alcohol 
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wash, pellet dried at 65°C. the sequencing was done on an automated sequencer (ABI 373A), by 
Ms. Rita Lange. 
  
II.16.2. %& '&(	 (&

II.16.2.1. Growth and Harvest of Bacteria 
All pGEX constructs were transformed into *  BL-21 cells. Cells were grown in a 37°C 
shaker at 180 rpm to an A600 of 0.4 and IIGP1 was expressed as a GST fusion protein upon 
overnight induction with 1 mM Isopropyl--D-thiogalactoside at 18°C where the proteins were 
most soluble. (The proteins were also expressed under varying temperature conditions (ranging 
from 18°C to 37°C), and different IPTG concentrations (0.1 mM to 1 mM), and induction at 
different optical density (A600 0.3 to 0.9) and varying the time of induction (2h- to overnight), in 
order to attain maximum solubility). The induced cells were pelleted at 1500 g for 10 min, 4°C; the 
cells were weighed and resuspended in 1x PBS, 2 mM DTT; (3 ml/gm) and were frozen at –80°C 
(Studier et al., 1990). 
 
II.16.2.2. Glutathione-Sepharose Affinity Chromatography 
The cells were thawed, 200 µM Pefabloc (Roth) was added to prevent protein degradation, 
and were lysed using a microfluidizer (Microfluidics corporation, USA) at a pressure of 600 kPa. 
The protein was extracted from the soluble fraction after centrifugation at 50,000 g, 4°C, 30 min. 
The protein was purified in a glutathione-Sepharose-Superflow affinity column (Amersham-
Pharmacia Biotech) which has a volume of 50 ml with a flow rate of 5 ml/min after equilibration 
with 1x PBS (40 mM Na2HPO4, 10 mM NaH2PO4 pH 7.5, 50 mM NaCl) and 2 mM DTE (two 
column volumes). The column was then washed with 10 column volumes of the buffer. The GST 
domain was cleaved by overnight incubation of the protein with thrombin (10 U/ml from Serva) on 
the resin at 4°C. The cut protein was eluted with 1x PBS, 2 mM DTT, 200 µM Pefabloc. The cut 
GST fragment was eluted with 20 mM Glutathione in 1x PBS buffer. The column was regenerated 
by washing with two column volumes of 6M Guanidinium hydrocloride in 1x PBS, and further with 
1xPBS (Guan and Dixon, 1991). 
 
II.16.2.3. Concentrating Proteins by Ammonium Sulphate Precipitation 
The eluted proteins from the glutathione affinity column was concentrated by ammonium 
sulphate precipitation. Ammonium sulphate was added to the eluted protein slowly to a final 
concentration of 3 M for an hour at 4°C, and then centrifuged at 15,000g for 30 min, 4°C. 
 25
II.16.2.4. Size-Exclusion Chromatography 
The protein was subjected to size exclusion chromatography in order to exchange the buffer 
and as a further purification procedure, in a Superdex 75 column either ( small or big depending on 
the amount of the protein) (Amersham-Pharmacia Biotech) equilibrated in buffer 2 (50 mM 
Tris/HCl (pH 7.4), 5 mM MgCl2, 2 mM DTE). The protein was loaded in a volume of 500 µl for 
the small column, or 2 ml for the large column, with a respective flow rate of 0.5 ml/ min and 0,1 
ml/ min respectively. All the fractions were collected and subjected to SDS-polyacrylamide gel 
electrophoresis. The fraction collector used was SigmaChrom GFC-1300 (Supelco,Belfonte, USA) 
(Bollag, 1994).  
 
II.16.2.5. Concentrating Proteins by Ultra-filtration 
After analysis of the fractions by SDS/PAGE, they were concentrated by a centrifugal 
concentrator (Vivascience, Lincoln,USA ) by centrifugation at 3000g, 4°C, to 50 mg/ml with a 10 
kDa cut off filter. Aliquots were shock-frozen in liquid nitrogen and were stored at –80° C. 
 
II.16.2.6. SDS-Polyacrylamide Gel Electrophoresis (Shapiro and Maizel, Jr., 1969). 
For the analysis of proteins, discontinuous one-dimensional gel electrophoresis was carried 
out under denaturing conditions in the presence of 0.1 % SDS (Laemmli method). It comprises a 
separating gel (10% 0r 12%) overlaid by a stacking gel (5%) as documented by Coligan 
 1997). 
The protein samples were dissolved in 1x SDS sample buffer (60 mM Tris/Hcl pH 6.8; 2.3% w/v 
SDS, 5% Glycerol; 0.1 mg/ml bromophenol blue (Sigma). B-mercaptoethanol (7%) was used as a 
reducing agent (added fresh), to disrupt the disulphide bonds. The samples were boiled at 100°C for 
5 minutes prior loading. The gels were run at 20 mA for 2 hours (small gels) or 40 mA (large gels) 
in a running buffer with 25 mM Tris; 190 mM Glycine; 0.1% SDS in mini-ProteanRII gel chambers 
(Biorad) or the big gel chambers. Ammonium persulfate (APS) Roth, Karlsruhe, Acrylamide 
(Roth), N,N,N’N’- Tetramethyl-ethylenediamine (TEMED), sigma (deisenhofen). After SDS-
PAGE the gels were stained with Coomassie staining solution (1.25g Coomassie Brilliant Blue R-
250 (Sigma), 500 ml methanol ; 100 ml acetic acid; 400 ml water) at RT, shaker for 20 min, 
destained with 30% methanol, 10% acetic acid, at RT, shaker, by repeatedly exchanging with fresh 
destain (Sedmak and Grossberg, 1977). The gels were dried under vacuum pressure at 80°C for 2 
hours. 
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II.16.3. "		 ! '"&$	 !'

II.16.3.1. Determination of Protein Concentration by Absorption Spectroscopy 
The concentration of IIGP1 was determined by ultraviolet-visible spectrophotometry at 280 
nm with the calculated molar absorption coefficient based on the number of tyrosines, tryptophan 
and cysteine residues (Gill and von Hippel, 1989). All the purified proteins were concentrated in 
the range of 40- 80 mg/ml. 
 
II.16.3.2. Fluorescence Spectroscopy  
Mant-nucleotides (mant = 2’/3’-O-(N-methylanthraniloyl)) were used as fluorescent probes 
as they exhibit protein-binding properties similar to those of natural nucleotides. The mant 
fluorophore allows the detection of conformational changes upon nucleotide-binding therefore 
serving as a monitor for protein-protein or protein-ligand interactions. The fluorescence 
measurements were done in Fluoromax 2 Spectro fluorimeter (SPEX instruments S.A., Inc., Edison, 
USA) in 0.4 x 1 cm2 cuvettes at 20°C in 50 mM Tris/HCl, pH 7.5, 5 mM MgCl2, 2 mM DTE.  
In the fluorescence titrations, the mant-nucleotides (0.5 µM) were excited at 360 nm and the 
fluorescence was monitored at 430 nm (Fluoromax 2, Spex Industries). The increase in 
fluorescence upon addition of the protein was measured , and at each step the values were averaged 
over one minute. The equilibrium dissociation constants Kd  was obtained by drawing a fit to the 
data as described by (Herrmann and Nassar, 1996)  
 
II.16.3.3. Stopped Flow Apparatus 
The binding of mant-nucleotides (mGMP, mGDP, mGTP and mGTPS) to all three purified  
IIGP1 proteins was measured by stopped-flow. In the stopped-flow experiments, at least a (5:1) 
ratio of protein to nucleotide concentrations were mixed together providing conditions for pseudo 
first-order binding kinetics.The time course of the increase in mant fluorescence upon binding of 
the protein to the mant-nucleotides was recorded (SM-17, Applied Photophysics, UK).  Mant 
fluorescence was excited at 360 nm and monitored through a 405 nm cut off filter. In each case a 
single exponential function could be fitted to the data, yielding the observed rate constant kobs. A 
linear fit of the plot of kobs versus protein concentration was obtained, the slope of the straight line 
denoting the association rate constant (kon) and the intercept, the dissociation rate constant (koff). 
The Kd values are calculated from the ratio of koff and kon. 
 
 
 27
II.16.3.4. Isothermal Titration Calorimetry 
Isothermal titration calorimetry (Microcal Inc., USA) was used to measure the binding of 
non-labelled nucleotides to IIGP1. The heat of binding was detected upon stepwise addition of 
nucleotide into a cell containing the protein. The data was fitted using the manufacturer’s software, 
yielding the enthalpy of the reaction, the dissociation constant (Kd) and the stoichiometry factor (N) 
as described in (Wiseman et al., 1989). 
 
 
II.16.3.5. Reverse-Phase HPLC 
The kinetics of hydrolysis of GTP to GDP by IIGP was monitored by Reverse-phase HPLC. 
Different concentrations of nucleotide and protein were mixed and incubated at 37°C in buffer 2 
and at different time points, aliquots were removed and subjected to HPLC analysis. Samples were 
run isocratically on a reverse phase C18 column (0.4 x 25 cm filled with 5µm ODS Hypersil, 
Bischoff, Leonberg, Germany) with a C18 pre-filter (10 x 4.6 mm with 5µm ODS Hypersil) in 7.5% 
acetonitrile in buffer 3 (10 mM tetrabutylammonium bromide, 100 mM K2HPO4/KH2PO4 (pH 6.5), 
0.2 mM NaN3) at a flow rate of 2ml/min. Nucleotides were detected at 252 nm in a UV absorption 
detector (Beckmann system gold 166). The concentration dependent GTPase activity of 
IIGPwt/IIGPm/IIGPHis was measured at a GTP concentration of 700 µM, and a range of protein 
concentrations. 
 
II.16.4. #	 #
 
Dynamic light scattering (DLS) was performed using a DynaPro molecular sizing 
instrument (Protein Solutions) equipped with a temperature control unit. The sample was filtered 
through a microsampler cuvette where 50 µl of the sample was passed through a filtering device 
using a 0.02 µm filter into a 12 µl Quartz cuvette. The sample (either protein alone, or protein with 
different nucleotides) in buffer 2 was illuminated by a 25 MW, 750 nm wavelength solid state laser. 
The time scale of scattered light intensity fluctuation for each measurement was evaluated by 
autocorrelation from which the translational diffusion coefficient (DT) was calculated. The 
molecular weight (MW) was estimated from the hydrodynamic radius RH which was derived from 
the DT using the Stokes-Einstein equation and the sample temperature (T= 4°C) using the standard 
curve of Mw versus RH for globular proteins.  
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The data was analysed by Dynamics 4.0 and Dyna LS software. For qualitative 
measurements, a conventional fluorescence spectrometer was used, where the sample was excited 
at 350 nm and monitored at the same wavelength. 
 
II.16.5. $ !! 
 
IIGP1 was crystallised using the vapour diffusion method at RT in hanging drops over a 
reservoir solution containing 10% PEG-20K (w/v), 200 mM MES pH 6.5, and 5% ethanol (v/v) 
with a protein concentration of 15mg/ml. The crystals grew over a time of 2-3 days to a size of 0.2- 
0.3 mm3. Seleno-methionine crystals were grown at 4°C, using hanging  drop setups with a 
reservoir solution containing 7.5% PEG 20K (w/v), 170 mM MES pH 6.5, 12.5 mM DTE and 1.5% 
heptanetriol (w/v) and a protein concentration of 10 mg/ml. 

II.16.6. !!"!#$

II.16.6.1. IIGP1 Specific Polyclonal Rabbit Antiserum ( 165) 
  
A 6 month old rabbit was obtained from a local breeder. The rabbit was sensitized 
subcutaneously with 100 µg purified recombinant IIGP1 in ‘complete Freund’s adjuvant’ (Difco 
Lab., Detroit, MI). Booster injections were given subcutaneously after four weeks (100 µg purified 
IIGP1 in ‘incomplete Freund’s adjuvant’ (Difco Lab., Detroit, MI) and intravenously after another 
three weeks (50µg purified IIGP1 in 0.01 M phosphate-buffered saline (PBS), pH 7.2). The final 
bleed was taken three weeks after another intravenous injection of 50µg purified IIGP1 in 0.01 M  
PBS, pH 7.2. Antisera from all the bleeds, the pre-bleed prior immunisation, first, second, third, and 
the fourth bleeds were obtained by centrifugation of the clotted blood at 2000g and stored at –20°C 
(Gilles et al., 1980). 
 
Western blots were done on IFN- induced and uninduced L929 cell lysates using different 
dilutions of the pre-bleed, first bleed, second bleed and the third bleed to check the specificity for 
IIGP1 as shown in the figure 2.1A and 2.1B. The first, second and the third bleeds recognise 
induced IIGP1 as indicated in the figure, as opposed to no staining in case of the uninduced and the 
pre-bleed control. The first and the second bleed do show additional background staining which is 
not observed in the third bleed.  
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Figure 2.1 Immunoblots of IFN- induced and uninduced L929 cells lysates with  165 antiserum. L929 cells were either induced or uninduced with 200 U/ml IFN-24 
h post induction cells were lysed under hypotonic buffer conditions, and the post-nuclear supernatant and pellet were subjected to SDS-PAGE and western blotting. The 
blots were processed with several dilutions of the different bleeds of the  165 antiserum, pre-bleed, first bleed and second bleed as shown in figure 2.1A and  pre-bleed 
and the third bleed in figure 2.1B. 
IFN- - 
IFN- + 
2.1A 
2.1B 


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II.16.6.2. Western Blot (Burnette, 1981) 
The gels after SDS-PAGE were transferred to nitrocellulose membranes by electroblotting. 
The gel was placed in contact to a nitrocellulose transfer membrane, and was sandwiched between 
four sheets of 3 MM Whatmann paper , two porous pads, and two plastic supports on either sides, 
soaked in a transfer buffer containing 25 mM Tris; 190 mM Glycine. The sandwich was then placed 
between platinum plate electrodes, with the nitrocellulose filter facing anode, and the transfer was 
carried out at RT for 1 hour with a current of 0.5V. Ponceau S staining was used to locate proteins 
(0.1% (w/v) Ponceau S (Sigma) in 5% (v/v) acetic acid) after western blotting. It is a rapid, 
reversible stain (washed with water) which has no deleterious effects on the proteins (Nakamura et 
al., 1985).
 
II.16.6.3. Growth and Culture of Eukaryotic Cells 
 
Mouse Embryonic Fibroblasts (MEFs) 
Primary embryonic fibroblasts were isolated from C57BL/6J and 129/sV mice at day 14 post 
coitum [Torres, 1997] and cultured as described in [Boehm, 1998]. 
 
B. L929 cells  (ATCC CCL-1) is a fibroblast cell line from CH3/An  mouse (kindly received from 
Ulrich Kalinke; EMBL, Monterontondo, Italy) 
 
L929 cells and MEFs were grown in 75cm2 polystyrene tissue culture flasks (Sarstedt) with 5% 
CO2 at 37°C in a incubator. IMDM  with high glucose, without sodium pyruvate (Gibco); 15% fetal 
calf serum (FCS, Sigma), 1 mM sodium pyruvate; Gibco BRL), 100U/ml penicillin (Gibco BRL), 
100 µg/ml streptomycin (Gibco BRL), 2 mM Glutamine (Gibco BRL), 1x non essential amino 
acids (Gibco). The cells (~ 106 cells /ml ) were washed twice in cold 1x PBS after trypsinisation  
(1x Trypsin, 2 min, RT), and resuspended in FCS (sigma) and 10% di-methylsulfoxide (DMSO, 
Sigma), immediately frozen at –80 °C. Transient transfection was done in L929 cells (grown upto 
80% confluency) in 60 mm dishes by using FuGENETM 6 reagent (Roche applied Science), a 
multiple component (mixture of cationic lipids) lipid based transfection reagent that complexes 
with DNA and transports DNA to the nucleus. 3µl Fugene /µg plasmid DNA was used, prior to 
diluting the Fugene reagent with serum free media. 
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II.16.6.4. Immunofluorescence 
L929 cells were induced with 200U/ml of IFN- or uninduced for 24 hours on sterile 22*22 
mm cover slips, or transfected with the respective constructs (harvested 48 hours post-transfection). 
The coverslips with cells were washed with 1xPBS for 5 min at room temperature (RT), and fixed 
with 3% paraformaldehyde at RT for 20 min, and further three subsequent washes with 1x PBS was 
done. The cells were permeabilised with wash buffer (1x PBS, 0.1% saponin) for 10 min and 
incubated with blocking buffer (1x PBS, 0.1% saponin, 3% BSA) for 1 hour. The respective 
primary antibody diluted to the appropriate working concentration with blocking buffer was used to 
stain the cells, in a Humid chamber for an hour. The cells were washed extensively with 10 ml 
wash buffer and incubated with the secondary antibody coupled to fluorescent Alexa 546 dye in a 
fluorescent chamber, and washed extensively as above. The cover-slips were mounted on the slides 
with a drop of Mowiol (anti.fade agent). The slides were analysed using an Axioplan II 
fluorescence microscope, a cooled CCD camera (Quantix) and the metamorph software (version 
4.5, Universal Imaging Corp.). For deconvolution the Auto Deblur software (version 6.001, 
AutoQuant Imaging Inc.) was used. Mowiol was prepared by mixing 6 g glycerol with 2.4 g 
Mowiol (Calbiochem) and 6 ml ultrapure water at RT for 2 h. Further, 12 ml 0.2 M Tris, pH 8.5 
was added to the mix, and incubated in hot water (50°C), O/N with frequent stirring to dissolve the 
Mowiol, centrifuged at 5000 g for 15' to remove the undissolved substances. Aliquots were frozen 
at –20°C. 
 
II.16.6.5. Cellular Fractionation 
L929 cells (80% confluent) in 100 mm dishes were induced with 200U/ml of IFN- or 
uninduced for 24 hours, or transfected with the respective mutants as described above. The cells 
were scraped using a cell scraper in 1x PBS after removing the medium, and resuspended in a 
hypotonic buffer (10 mM Tris, pH 7.5, 10 mM NaCl, 1.5 mM MgCl2 , and one tablet of Protease 
Inhibitor cocktail/10 ml buffer), 500 µl /107 cells, for 30’ at 4°C, ultracentrifuged using the Optima 
TLX Ultracentrifuge at 100,000g, 4°C, for 30 min. The supernatent (cytosolic fraction) was 
removed, the pellet (membrane fraction) was washed two times with hypotonic buffer to remove 
the residual cytosolic proteins loosely attached to the membrane. The membrane fraction was 
further lysed with a detergent buffer (1% Tx 100 in 1x PBS), for 30’, 4°C, and the lysate was 
homogenised by passing through a 22 ½ g needle, centrifuged at 15,000 g, 4°C, 15 min to remove 
the residual pellet. The pellet was washed two times with Tx-100 buffer, before processing them for 
SDS-PAGE. Solubilisation with different detergent buffers (NP-40, Tx-100 are non-ionic 
detergents; Chaps is an Zwitterionic detergent and digitonin, a neutral detergent) were done as 
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described above for Tx-100, using 1% w/v detergent solution in 1x PBS. Tx -114 extraction was 
done using 1% Tx-100 in 1x PBS, on IFN- induced L929 cells. The cells were incubated in the 
buffer for 1 hour, centrifuged at 15,000 g, 4°C, 15 min, and the post-nuclear supernatent was 
incubated at room temperature for 2-3 min, and centrifuged at 15,000 g, RT, 1’ to separate the 
aqueous and detergent phases. The detergent phase is washed twice to remove the residual soluble 
proteins. 
II.16.6.6. Immunoprecipitation (Harlow and Lane 1988) 
L929 cells (80% confluent) in 150 mm dishes were induced with 200 U/ml of IFN- for 24 
hours. The media removed, washed with 1x PBS, and starved with DMEM starvation medium for 
1h. The cells were labelled with PRO-MIX L- [35S ]  cell labelling Mix, 150 µCi for each 
plate, for 4 h. The cells were washed two times with 1x PBS, and then scraped into the lysis buffer 
(1x PBS, 1% of the desired detergent, and protease inhibitors), incubated for 1h at 4°C. The lysate 
was centrifuged at 15,000 g ,15 min, 4°C to remove the nuclear material, and  the supernatent was 
incubated at 4°C, for 2h with protein A beads coupled to the pre-bleed of the serum/ or a normal 
rabbit serum (coupling was done by mixing 50µl protein A beads and 50 µl serum or pre-bleed, at 
4°C, rotator, 2h) in order to reduce the nonspecific binding. The lysate was then incubated with 
protein A beads covalently coupled to 165 antiserum or  10D7, 10E7, 5D9 monoclonal antibodies 
at 4°C, in a rotator O/N. The beads were washed extensively after removing the supernatent, and 
the bound proteins were eluted with 1.5mM Tris pH 8.5, 0.5 % SDS by rotating at 4°C, 30 min. The 
samples were treated with 1x loading buffer, boiled for 5 min, and subjected to SDS PAGE. The 
gels were stained with Coommassie blue stain and de-stained as described above, and dried as a 
saran wrap/gel/3MM Whatmann sandwich in the BioRAD Gel dryer (Saran wrap facing up) for 2h 
at 60°C. The dried gel was subjected to autoradiography using a Kodak X-Omat AR film, and 
developed in a  AGFA Curix 60 X-ray device.  
Cross-linking of the 165 antiserum coupled to protein A beads was done to covalently couple the 
complex. The  protein A beads (50 µl) and 165 antiserum (10µl) was coupled at 4°C for 2 h, 
washed 5 times with 1x PBS, and then washed with 10 volumes of 0.2 M sodium borate (pH 9.0). 
Dimethyl pimelidimate (DMP) was used to a final concentration of 20 mM in 0.2 M sodium borate 
(pH 9.0), for 30 min, 4°C, in a Rotator. The reaction was stopped by adding 0.2 M ethanolamine 
(pH 8.0), and the beads were incubated  with 0.2 M ethanolamine (pH 8.0) for 2h, 4°C, in a rotator. 
The beads were then washed with 100 mM Glycine (pH 3.0) to remove the non-covalently bound 
complex, and washed with buffer before adding the lysates. The beads were pelleted at 10,000 g for 
30 sec during all the washes. 
 33
II.16.6.7. Analytical Gel Filtration  
L929 cells (80% confluent) in 150 mm dishes were induced with 200 U/ml of IFN- for 24 
hours, and the cells were lysed in a 1% thesit in 1x PBS as described above. Thesit belongs to the 
Triton series of non-ionic detergents which does not have an absorption at 280 nm.  The thesit 
lysates (0.5 ml) was fractionated in a calibrated Superose 6H R size exclusion column, equilibrated 
with 1% thesit in 1x PBS with a flow rate of 0.2 ml/min, and collected 0.2 ml fractions. The 
calibration of the column was done with several Molecular size markers. For the estimation of 
molecular size, elution volume (Ve) was analysed for several proteins, 29 kDa carbonic anhydrase 
has a elution volume (Ve) of 18.8 ml, 66 kDa Bovine Serum Albumin has a Ve of 17.3 ml, 150 kDa 
Alcoholic dehydrogenase has a Ve of 16.8 ml, 200 kDa B-amylase has a Ve of 16 ml, 443 kDa 
Apoferritin has a Ve of 15.3 ml, 665 kDa Thyroglobulin as a Ve of 13.7 ml. The void volume Vo 
was calculated as 8.2 ml by running Blue dextran which is 2000 kDa (Cutler, 1996). 
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III. RESULTS I 
 
III.A. "		 ! '!!! '

III.A.1. Recombinant IIGP1 Expression and Purification 
Recombinant IIGP1 proteins (IIGP1-wt, IIGP1-m and IIGP1-his) were expressed as N-
terminal GST fusion proteins in *BL-21 cells. Table 3.1 describes the three proteins, having 
the extension GSPGIPGSTT – at the N-terminus. The IIGP1-m protein originated from a cloning 
artefact: it differs from the wild-type by a two residue C-terminal truncation followed by the 
addition of 11 extra C-terminal residues. IIGP1-his has 6 histidine residues originally introduced as 
a C-terminal epitope tag. 
  
 
Table 3.1.  Description of the IIGP1 constructs.
 N-terminus C-terminus 
IIGP1-wt GSPGIPGSTT	 -
 
IIGP1-m GSPGIPGSTT	 -KLGRLERPHRD 
IIGP1-his GSPGIPGSTT	 -
-HHHHHH 
 
 
The purification of IIGP1-m is shown in figure 3.1. The incubation conditions were adjusted to 
maximise the yield of soluble proteins by varying the concentration of IPTG, temperature, time of 
induction and cell density as described in Materials & Methods. A considerable amount of the 
protein was found to be soluble upon overnight induction with 1mM Isopropyl--D-thiogalactoside 
at 18°C at an A600 of 0.4.  
Lane 1 and Lane 2 show the insoluble and the soluble portions of the induced protein after 
fractionation of the induced cell lysates. The soluble fraction was purified by affinity 
chromatography as described above (the expressed proteins are bound to the resin, as we see only a 
tiny amount in the flow through of the column as shown in lane 3). The GST domain of the fusion 
protein was cleaved by incubation with thrombin on the resin (lane 4). The eluted protein was 
further purified by size exclusion chromatography (lane 6). The purified protein was found to be 
nucleotide-free by reverse-phase HPLC. 
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Figure 3.1. Recombinant expression and purification of IIGP1-m 
Induced lysates of IIGP1-m expressing BL-21 cells fractionated to the soluble and insoluble forms (lanes 1, 2); The 
soluble fraction that remains unbound to the glutathione sepharose column is shown in lane 3. The eluate from the 
column after thrombin cleavage (lane 4). Lane 5 shows a fraction of the uncleaved protein as well as the cleaved GST 
domain after a wash with reduced glutathione. The pooled eluate (lane 4) after a Superdex 75 gel filtration run is shown 
in lane 6. 
 
 
III.A.2. Biochemical Characterisation of IIGP1
Comparative analysis of the biochemical properties of IIGP1-wt and two C-terminal 
modified forms, IIGP1-m and  IIGP1-his is explained in this section. Firstly, nucleotide binding 
parameters are described for the three proteins, followed by kinetics of GTP hydrolysis. 
 
III.A.2.1. Nucleotide Binding Features 
 
III.A.2.1.1. Equilibrium Titrations 
Nucleotide binding to IIGP1-m was monitored using mant-nucleotides. The increase in 
fluorescence upon mant nucleotide binding to the protein is used to determine nucleotide affinities. 
Figure 3.2 shows the titration curve for the increase in fluorescence upon the binding of 0.5 µM 
mant-GDP (mGDP) to IIGP1-m. IIGP1-m was added from a 600 µM stock solution and at each 
step the values for the increase in fluorescence were averaged over a period of one minute. 
Dissociation constants were calculated from curves fitted to the data as described in Materials and 
Methods. 
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Figure 3.2. Equilibrium titrations 
The increase in fluorescence upon binding of the mant-labelled GDP (0.5 µM) to IIGP1-m was measured at 430 nm, 
excited at 360 nm. A theoretical curve is fitted to the data yielding the Kd value. 
 
The nucleotide binding of mGDP, mGTPS, mGppNHp and mGDP.AlFx were determined by 
equilibrium titrations (table 3.2a). The binding affinities are in the micromolar range and mGDP 
shows higher affinity than mGTPS. mGppNHp, another non-hydrolysable analogue of GTP, shows 
weak binding in comparison to the other nucleotides (Kd of ~130 µM). Interestingly, we could not 
detect any binding of mGDP.AlFx to IIGP1 (data not shown), probably due to the relatively strong 
binding of mGDP itself, suggesting that AlFx may not be required to stabilise the binding. 
 
Table 3.2a. Kd value (µM) for the binding of fluorescent and non fluorescent nucleotides to IIGP1-m by different 
methods. 
Nucleotides 
 
Equilibrium Titrations 
A.2.1.1 
Calorimetric Titrations 
A.2.1.2 
Stopped-Flow 
A.2.1.3 
GDP  2.45  
mGDP 0.90  0.97 
mGTP   16.1 
mGTPS 5.20  15.7 
GTPS  8.0  
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III.A.2.1.2. Isothermal Titration Calorimetry 
The interaction of unlabelled nucleotides with IIGP1 was measured by isothermal titration 
calorimetry in order to control for possible interference of the mant-group in the fluorescence-based 
binding assay. Figure 3.3 (upper lane) shows the raw data for binding upon step-wise addition of 
GDP to IIGP1-m. The exothermic process is reflected in a negative power pulse from which the 
heat of the reaction is calculated by integration. The enthalpy of the reaction normalised to the 
concentration of injected GDP was plotted against the molar ratio of GDP and IIGP1-m as shown in 
the lower panel. The parameters defining the theoretical curve yielded a Kd of 2.5 µM, and an 
enthalpy of association of –15 kcal/mol. In addition, 1:1 stoichiometry is evident from the data. The 
results from table 3.2a suggest that IIGP1-m has similar binding affinities to mant-labelled as well 
as unlabelled nucleotides. 
 
 
 
 
 
Figure 3.3.  Isothermal titration calorimetry 
Thermodynamics of GDP binding to IIGP1-m was analysed by ITC. The upper panel shows the change in heating 
power upon injection of 1.66 mM GDP into a cell containing 43.8 µM IIGP1-m solution. The heat of the reaction is 
plotted against the molar ratio of GDP to IIGP1-m in the lower panel. 
 
III.A.2.1.3. Dynamics of Nucleotide Binding 
The dynamics of nucleotide binding to IIGP1 were determined by stopped flow using mant 
nucleotides. The IIGP1 protein was used in a large molar excess over the nucleotide in order to 
obtain pseudo-first order reaction kinetics (shown for IIGP1-m in figure 3.4A).  
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Figure 3.4.  Stopped flow measurements 
A. The increase in fluorescence upon mixing 0.2 µM mGDP with 4 µM IIGP1 is monitored through a 405nm cut off 
filter after excitation at 360nm. A single exponential curve is fitted to the data (inset above) to obtain the observed rate 
constant kobs, and a linear fit to the plot of the observed rate constant versus protein concentration is shown in the figure, 
deriving the kon and koff.  B. The exponential decrease of fluorescence upon addition of excess GDP (400 µM) to IIGP1 
(4.8 µM) – mGDP (3.9 µM) pre-formed complex is shown in the inset below yeilding the koff. 
 
A single exponential function is fitted to the data, where the resulting time constant corresponds to 
the inverse observed rate constant kobs (figure 3.4A, upper inset). The observed rate constants for 
the binding of mGDP were plotted against IIGP1 concentration. The slope of the curve denotes the 
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association rate constant (kon) and the intercept, the dissociation rate constant (koff). koff was also 
measured in a displacement experiment by the addition of excess unlabelled nucleotide to IIGP1-
mGDP pre-formed complex. This leads to a quasi-irreversible dissociation of mGDP and therefore 
to a single exponential decrease of fluorescence as shown in Figure 3.4B. The binding of different 
nucleotides to IIGP1-m using equilibrium methods (above) is compared with Kd values determined 
by stopped flow, represented in Table 3.2a. The three employed methods show comparable results 
for nucleotide binding. The nucleotide binding affinities for IIGP1-wt, and the two C-terminal 
mutants IIGP1-m and IIGP1-his are tabulated in table 3.2b, where it is apparent that they have 
similar values, and the C-terminal end of IIGP1 is not important for nucleotide interactions.  
 
Table 3.2b. Association and dissociation rate constants and Kd values for the binding of fluorescent nucleotides and 
non hydrolysable analogues to IIGP1- wt / IIGP1- m / IIGP1- his. 
 
Nucleotides k µM-1s-1 koff (displacement)s-1  Kd (µM) 

IIGP1-wt 
IIGP1-m 
IIGP1-his 
 
1.55 
1.65 
1.31 
 
0.99 
1.6 
0.70 
 
0.64 
0.97 
0.53 

IIGP1-wt 
IIGP1-m 
IIGP1-his 
 
0.98 
1.30 
1.11 
 
21.6 
21 
14.28 
 
22 
16.1 
12.9 

IIGP1-m  
 
4.20 
 
66 
 
15.7 
 
 
In detail, the association rate constants are similar for the different nucleotides, but the dissociation 
rate constants vary. The smaller koff for mGDP accounts for stronger binding compared to mGTP 
and its non-hydrolysable analogue, as observed in the equilibrium titrations described above (table 
3.2a). In summary, results from all different methods employed show that IIGP1 has micromolar 
binding affinities for different nucleotides and GDP has a 15-fold higher affinity to IIGP1 than 
GTP. 
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III.A.2.2. GTP Hydrolysis 
In GTPases, the identity of the nucleotide bound to the protein and the rate of conversion of 
GTP to GDP by hydrolysis are crucial factors determining their functional regulation (Bourne et al., 
1991). The rate of GTP hydrolysis and GDP formation was analysed by reverse-phase HPLC. The 
activity of the three forms of IIGP1, IIGP1-wt, IIGP1-m and IIGP1-his at 2 – 50 µM was analysed 
over varying GTP concentrations (0.05 – 2 mM). Figure 3.5 documents the hydrolysis of GTP to 
GDP by IIGP1. 
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Figure 3.5. Time course of GTP hydrolysis by IIGP1 at 37°C 
The rate of GTP hydrolysis and GDP formation was analysed by HPLC as described in Materials and Methods. IIGP1 
hydrolyses GTP to GDP. The percentage breakdown of 700 µM GTP (open circles) with 50 µM IIGP1 to GDP (closed 
circles) with time is shown in the figure. 
 
ATP was not hydrolysed, confirming nucleotide specificity and indicating that our preparations 
were free of phosphatases. IIGP1 hydrolyses GTP to GDP and not to GMP as described for hGBP1, 
the member of the p65 GTPase family (Praefcke et al., 1999). A representative curve for the time 
course of GTP hydrolysis by IIGPm at 37°C is shown in figure 3.5. The rate constant for GTP 
hydrolysis was obtained using initial rates as product inhibition was observed with the progression 
of the reaction. The catalytic activity of IIGP1 at different protein and nucleotide concentration was 
determined as shown in figure 3.6. Michaelis Menten equation was applied to a plot of specific 
activity (at a range of protein concentration) versus substrate concentration. Intriguingly, a small 
increase in Km was observed, with varying protein concentrations. This suggests functional 
cooperativity between IIGP1 molecules. 
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Figure 3.6.  Michaelis Menten plot 
The specific activity of IIGP1 at a range of protein concentrations (2 – 50 µM) were plotted against the substrate 
concentration. The Michaelis Menten equation was fit to the data to derive the parameters. Vmax of 2 min-1 was obtained 
for the highest concentration checked (50 µM IIGP and 2 mM GTP). 
 
 
In order to investigate this effect more precisely, the dependence of the specific GTPase 
activity on IIGP1 concentration was measured at a fixed GTP concentration of 700 µM as shown in 
Figure 3.7 (black circles- IIGP1-m, open circles- IIGP1-wt). The specific activity increased 
approximately 7-fold with increasing protein concentration, from the lowest measured activity at 
0,1min-1 to about 0,7 min-1. The maximum specific rate of GTP hydrolysis by IIGP1 was close to 2 
min-1 (see Fig. 3.6 where 50 µM IIGP1-m and 2 mM GTP was used). The increase in activity of the 
protein with increase in protein concentration observed in the case of IIGP1-wt and IIGP1-m 
demonstrates a cooperative mechanism of GTP hydrolysis. Intriguingly, the GTP hydrolysis rate of 
IIGP1-his C-terminally modified protein showed marginal if any protein concentration dependence 
over the tested range, remaining at or close to the basal rate of 0,1 min-1 (figure 3.7 black triangles). 
There is a slight increase in the activity of IIGP1-his is observed, which was also noticed when the 
activity assay was repeated in the presence of BSA. 
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Figure 3.7. Co-operativity 
IIGP1 shows a co-operative GTPase activity, with a seven fold increase in the specific activity of the protein at a 
concentration of 700 µM GTP in the case of IIGP1-wt (open circles) and IIGP1-m (closed circles) is shown in the 
figure. The IIGP1-his protein (closed triangles) fails to show co-operativity. 
 
III.A.2.3.Oligomerisation 
III.A.2.3.1. Time and GppNHp Dependent Oligomerisation 
GTPases with co-operative activity are known to form enzymatically active oligomers in the 
presence of nucleotides (Haller and Kochs, 2002). The oligomerisation of IIGP1-m was 
investigated using dynamic light scattering at 20oC at protein concentrations of 50-100 µM and 
nucleotide (GDP, GTP and GppNHp) concentrations of 1 mM. The change in the hydrodynamic 
radius (RH) of IIGP1 (derived from the unimodal fit analysis by Dynamics 4.0 software) versus time 
was plotted for each of the data sets with and without nucleotides. Figure 3.8 shows the time 
dependent oligomerisation of IIGP1-wt with GTP and GppNHp. A striking increase in 
hydrodynamic radius was detectable after the addition of GTP, and also after the addition of 
GppNHp, but to a lesser degree in the latter case. No detectable higher molecular forms were found 
with the apoprotein (nucleotide free) or in the presence of GDP as they have a hydrodynamic radius 
(Rh) of  3.1 nm, corresponding  to the expected molecular weight of 47 kDa. The difference in 
oligomer formation between GTP and GppNHp bound forms could be due to their difference in 
binding affinities. 
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Figure 3.8. Dynamic light scattering 
The time dependent increase in the hydrodynamic radius (Rh) protein oligomers in the absence and presence of 
nucleotides are depicted for IIGP1-wt and IIGP1-his. The difference in oligomer size of IIGP1-wt with GTP and with 
GppNHp is clearly visible. The values for the nucleotide free IIGP1-wt (NF), IIGP1-wt-GDP (GDP), and and IIGP1-
his GTP (His GTP) overlap due to their same Rh, and is visible as a single curve. 50 µM of IIGP and 1 mM nucleotides 
were used. The Rh of  3 nm corresponds to 47 kDa. 
 
III.A.2.3.2. C-terminal end is Essential for the Formation of Higher Molecular Species 
As shown in figure 3.7, modification of the C-terminus of IIGP1 by addition of a His tag 
prevented IIGP1-his from showing co-operative GTPase activity. It was therefore of interest to 
know whether the C-terminal modification also blocked the formation of nucleotide triphosphate 
binding oligomers. Using the dynamic light scattering assay, IIGP1-his analysis, unlike IIGP1-wt, 
did not build up oligomers in the presence of GTP and GppNHp. (figure 3.8, where IIGP1-his 
shows an overlap with IIGP1-wt, IIGP1-wt GDP). The hydrodynamic radius of IIGP1-his in the 
presence of GTP persists at around 3 nm, thus a monomer. 
 
III.A.2.3.3. Fluorescence Scattering Experiments Confirming GTP Dependent Oligomerisation 
Since oligomerisation was possible only in the presence of GTP or GppNHp, and not in the 
presence of GDP, the reversibility of these oligomers was tested with respect to GTP hydrolysis. In 
order to show directly the relationship between IIGP1 catalysed GTP hydrolysis and oligomer 
formation, light scattering was done in a fluorescence cuvette from which aliquots for nucleotide 
analysis were taken simultaneously. The time course of the oligomerisation in a solution of GTP (1 
mM) and IIGP1 wt (50 µM) is shown in figure 3.9.  
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Figure 3.9. Light scattering 
GTP dependent oligomerisation shows reversibility upon GDP formation. The time course of the scattered light 
intensity was detected at 350 nm, in a solution of 1 mM GTP and 50 µM IIGP solution. The time dependent 
oligomerisation and the time course of GTP hydrolysis (open circles). is overlayed in the graph to show the association 
of these two processes. 
 
The initial rise in light scattering is followed by a slow decrease due to progressive hydrolysis of 
GTP. This time dependent oligomerisation leads to a turbid solution, is visible, but reverts to a clear 
solution. The decrease in turbidity is therefore not due to flocculation (falling down of particles in 
the cuvette), but due to GTP hydrolysis and dissolution of the particles. The formation of GDP 
inhibits oligomerisation, as it has a high binding affinity, as well as competition with GTP to bind 
IIGP1.  The light scattering trace in figure 3.9 showing the reversibility of the IIGP oligomers, and 
is overlayed with the time course of GTP hydrolysis (for the same nucleotide and protein 
concentrations) to delineate the relationship between the two processes. However, the reversibility 
of the oligomers was not visible in the previous experiment due to the measurements only in short 
time ranges.  
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To describe the properties of IIGP1 , a detailed cellular characterisation of IIGP1 was 
carried out. For cellular studies, L929 mouse fibroblasts or mouse embryonic fibroblasts (MEFs) 
were grown and cultured in IMDM or DMEM respectively as described in Materials & Methods. 
The IIGP1 wt and mutant constructs were all cloned into the eukaryotic expression vector pGW1H, 
and all transfections were done using a lipid based transfection reagent as described above. The 
cells were stimulated with 200 U/ml of Mouse IFN- for 24 hours unless specified. 165 rabbit 
antiserum was generated against recombinant purified IIGP1 as described. 
IIGP1 is stimulated preferentially by IFN type I and also by IFN type II in various cells including 


	 infected, or LPS stimulated macrophages, endothelial cells, activated T cells and 
mouse embryonic fibroblasts. The expression of IIGP1 has also been documented in 


	 infected spleen and liver cells. Constitutively expressed IIGP1 was not detectable in 
the mRNA level, as well as the protein level (Boehm et al., 1998; Zerrahn et al., 2002). Localisation 
of IIGP1 was done by Martens and Boehm et al (unpublished data) showing the association with 
the endoplasmic reticulum. However, the localisation of IIGP1 in Golgi apparatus has been 
documented by Zerrahn et al 2002.  
 
To understand the cellular properties of IIGP1, and its importance, this section attempts to describe 
IIGP1 with respect to its localisation, cellular distribution, the associated molecules and several 
features of membrane attachment. 
 
III.B.1. Localisation Studies on IIGP1 
 
Immunofluorescence studies was done on L929 fibroblasts that were stimulated with 200 
U/ml of Mouse IFN- / or transfected with IIGP1-wt, to analyse the endogenous and the transfected 
IIGP1. The C-terminally tagged IIGP1-his was initially made to be used in several cell biological 
analysis. 24 hours post transfection or induction, the cells were stained with IIGP1 specific 165 
rabbit antiserum. Endogenous IIGP1 localisation is defined by a typical perinuclear, nuclear 
envelope / ER staining with  165 as shown in the upper panel of  figure 3.10, whereas transfected 
IIGP1 has a slightly different pattern of dots (not identified) in addition to the ER staining.  
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Figure 3.10. Localisation of IIGP1.  
Cells grown on cover-slips were exposed to control conditions or to 200 U/ml IFN- or transfected with FuGENETM 6 
reagent, a multiple component lipid based transfection reagent. The cells 24h post transfection/induction were fixed 
with 3% paraformaldehyde, and permeabilised with 0.1% saponin and stained with 10D7antibody, and used Alexa 
546 coupled secondary antibody. The staining was analysed using Axioplan II fluorescence microscope, a cooled CCD 
camera and the pictures are processed using a  metamorph software. The distribution of IFN- induced, transfected  
IIGP1 and IIGP1-his respectively is shown in the upper panel. The lower panel shows the co-localisation of 
endogenous (IFN-induced) IIGP1 merged with transporter associated with antigen processing (TAP) . 
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The transfected IIGP1 his  forms a ring like pattern in the perinuclear region, in addition to the 
typical reticular ER stain and sometimes, the dotted pattern. The localisation of IIGP1 in the ER 
was confirmed by colocalisation with an ER transmembrane protein transporter of antigen 
presentation (TAP) in the lower panel of figure 3.10. The ER staining of IIGP1 is shown in red, and 
the TAP staining in green, and the colocalisation is clearly demonstrated by the merge, as shown. 
However, there is an additional dotted and the ring pattern of IIGP1, the identity of which is 
unknown. The co-localisation studies were done by Martens et al (unpublished results)  
 
III.B.2. Distribution of IIGP1 in the Cell 
IIGP1 sequence contains neither any signal sequences, or ER retention or retreival signal 
sequences (Nilsson and Warren, 1994; Kalies and Hartmann, 1998). Therefore we suppose that 
IIGP1 is not located in the lumen of the ER, and is probably associated peripherally with the ER, 
from the cytosolic side. To understand the location of IIGP1, IFN- induced L929 mouse fibroblasts 
were lysed in a hypotonic buffer and separated the membrane and soluble fractions. This led to the 
partitioning of IIGP1 to a prominent membrane bound fraction and a smaller cytosolic fraction. 
This is depicted in figure 3.11A as the supernatent (S) and the Pellet (P) fractions representing the 
soluble and the membrane bound forms in lane 5 and 6 respectively. The levels of IIGP1 
constitutive expression in the IFN- uninduced control experiment seems to be undetectable (lane 
1-4).  
 
In order to study the membrane associated IIGP1, very mild detergents were used to solubilise 
membranes. They can isolate lipoproteins into detergent micelles, without significant denaturation 
of the protein, because of their weaker detergent action (Neugebauer, 1990). Lane 7 shows the 
detergent solubilisation of  IIGP1 with NP-40 as described in Materials & methods, a very small 
amount of insoluble IIGP1 is seen in lane 8. TAP the ER transmembrane protein is used as a 
positive control for the partitioning, where all the protein is membrane bound (lane 2,6), and is 
completely solubilised upon detergent lysis (lane 3,7). TAP is constitutively expressed in the cell 
(lane 2), and is also stimulated upon IFN- induction as shown in lane 6 (Seliger et al., 1997). 
Additionally, the solubilisation of the membrane bound IIGP1 with several mild detergents were 
tested, as they have distinct solubilisation properties (NP-40, Tx-100 are non-ionic detergents; 
Chaps is an Zwitterionic detergent; digitonin, a neutral detergent). The solubilisation of IIGP1 with 
different detergents is shown in figure 3.11 B 
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Figure 3.11. Distribution of IIGP1 in the IFN- induced L929 cells.   
L929 cells induced or uninduced with 200 U/ml IFN-, 24h post induction, cells were lysed under different buffer 
conditions (hypotonic buffer/Tx-100/Digitonin/Chaps/NP-40), and the post-nuclear supernatent and pellet were 
subjected to SDS-PAGE and western blotting. A.Comparison of the distribution of IIGP1 in IFN- induced and 
uninduced (NP-40/ hypotonic) lysates using TAP as control. B. Solubilisation of IIGP1 with different detergents. 
 
III.B.3. Interaction Molecules 
 
III. B.3.1. Size Exclusion Chromatography 
  characterisation of IIGP1 recombinant protein showed nucleotide dependent 
oligomerisation. To analyse whether endogenous IIGP1 exists in a monomeric or oligomeric state, 
size exclusion chromatography was carried out on IFN- induced, 1% thesit treated L929 cells. The 
proteins in the lysate fractionated into various molecular size components depending on their size 
as shown in figure 3.12.  
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Figure 3.12. IIGP1 forms a higher molecular complex. 
L929 cells induced or uninduced with 200 U/ml IFN-, 24h post induction, cells were lysed with 1% thesit buffer, and 
the post-nuclear supernatent is loaded on a Sephacryl 300 column. All the fractions were collected and subjected to 
western blotting. The profile of the column run is aligned to the blots of the collected fractions. Immunoblot of the 
fractions of the different column runs shown are recombinant IIGP1, 1% SDS, and 3M urea and 165 antiserum was 
used for the analysis.  [V0 =12.5 ml; Ve for the different markers are indicated]. 
 
Immunoblot of all the collected fractions with the 165 polyclonal serum sorted IIGP1 subsisting 
as a higher molecular complex of ~ 150 kDa. On the contrary, recombinant IIGP1 fractionated as a 
monomer corresponding to the peak fractions 42-45. Interestingly, when the membrane and the 
soluble forms were fractionated (lane 5 and 6 in figure 3.11A) and subjected to size exclusion 
chromatography, different elution profiles were observed for the two fractions, molecular sizes of 
~150 kDa and ~ 47 kDa respectively (figures not shown). Henceforth, association to membranes is 
likely to be an important feature for the maintainance of this complex.  
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However, the nature of the complex was checked by treatment with denaturants (1 % SDS, 3M 
urea), prior loading the lysates on the column. The complex can be disrupted by the addition of 1% 
SDS as indicated by the elution as monomers in the figure, but not with 3M urea which still retains 
the complex (3M urea was probably not mild to disassociate the complex). However, the 
disassembly of the complex with SDS asserts the credibility for lipid mediated interactions. IIGP1 
has the myristoylation sequence MGQLFSS, in the N-terminal region. This modification is 
probably responsible for IIGP1 molecules to stick together, either forming a homotypic complex or 
a heterotypic complex with other proteins due to their increased hydrophobicity.  
 
III.B.3.2. Immunoprecipitation 
 
III.B.3.2.1. Immunoprecipitatation of IIGP1 in MEFs with 165 
Another approach was taken to analyse the molecules associated with IIGP1, whether there 
exists a stable IIGP1 complex, and if so, to identify components of the complex. Since 165 is a 
good reagent for immunofluorescence and western blotting as described before, the ability to 
immunoprecipitate endogenous (IFN- induced) IIGP1 with this polyclonal serum was analysed. 
IFN- induced mouse embryonic fibroblasts (MEFs) was subjected to immunoprecipitation with 
165 coupled protein A sepharose beads. IIGP1 was selectively extracted from the whole cell 
lysate analysed by the immunblot with 165 in figure 3.13A. The IFN- induced lysate (control) 
shows the expression of IIGP1 indicated by the arrow ~ 47 kDa. The precipitation of IIGP1 with 
165 is clearly seen in comparison to the lack of signal in the uninduced cell lysate (negative 
control). 
 
III.B.3.2.2. Co-precipitation of IIGP1 and Partners with 165 in MEFs. 
As shown in figure 3.12, IIGP1 subsists as a higher molecular weight complex, either 
homotypic or heterotypic. Since the IIGP1 specific polyclonal serum, 165 precipitated IIGP1 from 
IFN- induced mouse embryonic fibroblasts, the co-precipitation of other molecules along with 
IIGP1 was checked by metabolic labelling. IFN- induced, [35S] Met labelled, MEF cell lysates 
were subjected to immunoprecipitation with 165 coupled protein A beads. Prior, the lysate was 
passed through protein A coated beads bound to a non-relevant serum to remove the unnecessary 
background (pre-clear).    
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Figure 3.13.A. Immunoblot showing the precipitation of IIGP1.  
MEFs induced or uninduced with 200 U/ml IFN-, 24h post induction, were lysed with 1% NP-40 containing buffer, 
and precipitated with  165 coupled protein A sepharose beads. The IFN-induced lysate showing IIGP1 expression 
(lane 3). The immunoprecipitated IIGP1 (~ 47 kDa indicated by blue arrow) from induced MEF lysates (2nd lane) in 
comparison to no IIGP1 in the uninduced lysates (1st lane). 
 
 
The 35S Met incorporated immunoprecipitated proteins are separated on a 10% SDS PAGE as 
shown in the figure 3.13B, where the uninduced lysate (IFN-)  is used as negative control, and all 
the samples are loaded in duplicate. IIGP1 is immunoprecipitated as indicated by the arrow ~ 47 
kDa which is not present in the uninduced, and additionally, two other proteins of different sizes are 
co-precipitated as depicted (~ 100 kDa and ~ 40 kDa). These molecules seem not to be present in 
the induced pre-clear ruling out the possibility that these two molecules are interacting 
nonspecifically  with the 165 serum. 
 
 
III.B.3.2.3. 165 can also Co-precipitate the Same Molecules in L929 Cells. 
In order to confirm the previous results, the co-immunoprecipitation experiment was 
repeated with L929 cells, additionally the lysates were prepared using different detergents for 
membrane solubilisation. The solubilisation of IIGP1 from the membrane with several detergents 
has been shown in figure 3.11A and 3.11B. IFN- induced and uninduced [35S] Met/Cys labelled 
L929 cells were lysed with buffer containing 1% NP-40/ 1% Chaps/ 1% Tx-114. Additionally, 
165 serum was covalently coupled to the protein A beads in order to reduce the background from 
the antibody from loose coupling to the beads. 
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3.13.B. Co-immunoprecipitation in MEFs 
IFN- induced or uninduced MEF cells, were metabolically labelled with [35S] Met, and were lysed  with 1% NP-40 
containing buffer and precipitated with 165 coupled protein A sepharose beads. The samples are loaded in duplicates. 
Prior immunoprecipitation (IP), the lysates were pre-cleared with the pre-immune serum denoted as pre-clear in the 
autoradiogram. In addition to the precipitation of IIGP1, there appears to be co-precipitation of two bands in IFN- 
induced samples which is not visible in the uninduced control lanes, marked by the red asterix.  
 
 
Immunoprecipitation under these conditions obtained the same two proteins of distinct size 
described before, and another additional protein ~ 47 kDa was visible which is not seen in the 
uninduced samples. This observation was consistent regardless of the detergent used, NP-40 or 
Chaps (figure 3.14A ; lane 1 and 3 uninduced, lane 2 and 4 induced). Besides, the differential 
distribution of IIGP1 in the membrane and the cytosol has been documented (figure 3.11A, lane 5 
& 6), and also the different molecular forms in the respective fractions (soluble form showing ~ 47 
kDa and membrane bound form ~150 kDa, data not shown). This led to the supposition for different 
patterns of co-precipitating molecules with the soluble and membrane bound forms. Therefore, the 
detergent Tx-114 was used since it has a temperature induced phase partitioning (4°C to 37°C), 
where the hydrophilic proteins (in this case, lumenal or peripherally associated  
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proteins) into the aqueous phase, and the hydrophobic proteins (integral membrane proteins or 
amphipathic) in the detergent phase. Upon using these aqueous and detergent fractions for 
immunoprecipitation with the165 serum, the co-precipitation of  the three proteins prevailed in 
the aqueous phase along with IIGP1 precisely as before, whereas only IIGP1 was precipitated in the 
detergent fraction, although equal distribution of IIGP1 in both the fractions was evident (figure 
3.14A).  
 
To conclude, the aqueous phase showing similar results to the whole cell lysates is not understood. 
Either, the co-precipitated proteins observed in the aqueous phase are not specific, or Tx-114 
solubilises a portion of the complex from the membrane (two populations of 47 kDa and 150 kDa 
observed when the Tx-114 aqueous phase is subjected to size exclusion column as opposed to only 
47 kDa with the soluble IIGP1, data not shown). On the other hand, the three co-precipitating 
molecules were not observed, possibly due to the temperature shift in this experiment which 
destroys the complex. 
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Figure 3.14. Three different proteins co-precipite with IIGP1 in L929 cells. 
A.  IFN- induced and uninduced L929 cells were metabolically labelled with [35S] Met/Cys and lysed in either 1% 
NP-40, 1% Chaps or 1% Tx-114 containing buffer, and immunoprecipitated with 165 coupled protein A sepharose 
beads. Autoradiography of the precipitated proteins shows three proteins along with IIGP1 in the induced lane, in 
comparison with the bands in the uninduced samples. B. Immunoblot of the IP samples from NP-40 and Tx-114 
detergent lysis shows no staining of the co-precipitating proteins. 
 
Immunoblotting with 165 on the immunoprecipitated material from Nonidet P-40 (NP-40) and 
Tx-114 derived IFN- induced and uninduced L929 cell lysates. Only IIGP1 was detected by 165 
and not the three putative co-precipitated proteins, as in  figure 3.14 B. This strongly suggests that 
the co-precipitating proteins bind specifically to IIGP1. However, these molecules are yet to be 
analysed and identified. 
 
III.B.3.2.4. Immunoprecipitation with the Monoclonal Antibodies 
To determine the specificity of the co-precipitated molecules, immunoprecipitation of IIGP1 
was analysed using monoclonal antibodies designated 10D7, 10E7, 5D9. IFN- induced and 
uninduced L929 lysates were immunoprecipitated with the monoclonal antibodies as previously 
described. Immunoblot of the immunoprecipitated lysates with 165 serum was carried out to 
monitor IIGP1 precipitation by the monoclonal antibodies. The lysate control shows a distinct 
protein corresponding to the size of IIGP1, which is 47 kDa. All the antibodies precipitate IIGP1 
with 10D7 giving a very weak signal in comparison to the other antibodies in figure 3.15, upper  
3.14B 
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panel. On the other hand, to test the interaction of the other p47 GTPases with IIGP1, the same 
immunoprecipitated samples were analysed by western blotting with reagents specific for three 
other members of the p47 family. No positive staining was visible for the three p47 GTPases 
analysed; IGTP, LRG47,  TGTP. The expression of these proteins upon IFN- induction are 
shown in the first lane. To conclude, the P47 GTPases that are tested in this experiment do not 
interact with IIGP1. 
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Figure 3.15. Immunoprecipitation with three distint monoclonal antibodies. 
L929 cells were induced or uninduced with 200 U/ml IFN-, 24h post induction, cells were lysed with 1% NP-40 
containing buffer, and precipitated with  either  10D7,  10E7,  5D9 coupled protein A sepharose beads. 
Immunoblot showing the precipitation of IIGP1 with the monoclonal antibodies; 10D7, 10E7 and 5D9 is shown in the 
upper panel. The subsequent panels stained for IGTP, LRG-47 and TGTP do not show any positive staining on the 
IIGP1 precipitated samples. The first two lanes indicate control lysates (the induced and the uninduced),  the first lane 
of the last three panels show the expression of IGTP, LRG47 and TGTP respectively upon IFN- induction. 
 
III.B.4. Properties of Membrane Associated IIGP1 
 
III.B.4.1. Myristoylation is Important for Membrane Attachment. 
IIGP1 has a putative N-terminal myristoylation site MGQLFSS which refers to the 
attachment of a fourteen-carbon saturated fatty acid (C14:0) to the glycine residue by an amide 
bond. The lipidated proteins are found to be associated with membranes post modification, 
implying access for potential interactions (Boutin, 1997). To analyse the influence of 
myristoylation, single point substitution of the glycine residue to alanine was done, which is known 
to prevent myristoyl modification. Cellular fractionation into the soluble and membrane bound 
forms indicate solubilisation of a significant proportion of the membrane bound IIGP1 in 
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comparison to the wild type. This is demonstrated in figure 4.5, where the distribution of the 
transfected myristoylation mutant IIGP1-Nm is shown in comparison to the transfected IIGP1-wt.   
 
 
IIGP1-wt IIGP1-Nm
 
 
Figure 3.16. Myristoylation is important for membrane attachment. 
L929 cells grown on cover slips, and were transfected with the respective mutants for 24 h with FuGENETM 6 reagent. 
The cells 24 h post transfection were fixed with 3% paraformaldehyde, and permeabilised with 0.1% saponin and 
stained with 10D7 antibody, and used Alexa 546 coupled secondary antibody. The staining was analysed with an 
Axioplan II fluorescence microscope, a cooled CCD camera and the pictures are processed using the Metamorph 
software. Immunofluorescence studies with IIGP1-Nm mutant (G2A), prevents myristoylation and renders the protein 
more soluble as shown by the more soluble staining in the IIGP1-Nm mutant. 
 
 
However, there is a small fraction of the protein still in the membrane fraction, independent of this 
fatty acid modification, showing that it possibly utilizes another mode of attachment to the 
membranes. Immunofluorescence studies on IIGP1 Nm in L929 cells, shows a more diffused 
pattern compared to the transfected IIGP1 wt cellular distribution as shown in figure 3.16. This 
suggests the significance of this post-translational modification on IIGP1 for its association with the 
membrane. 
 
III.B.4.2. C-terminal Mutants 
Several biochemical properties of the two C-terminal mutants (Table 1), IIGP1-m with the 
two different and 9 extra residues and IIGP1-His with the C-terminal his tag (6x) has been 
described. To recapitulate, the IIGP1-m has similar features as the wild type, but not IIGP1-his. 
 studies demonstrated that IIGP1-m and IIGP1-wt and IIGP1-his maintained similar binding 
affinities for the nucleotides irrespective of their different c-terminal modifications. All the three  
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proteins hydrolyse GTP to GDP, but with different features. IIGP1-his failed to demonstrate 
cooperativity and GTP oligomerisation as opposed to the former two proteins. This articulates the 
influence of the 6x his residues, although the IIGP1-m likewise has nine extra residues and still 
behaves like the wild type, which is a contrariety. Probably, the nature of the two different C-
terminal extension is the reason for such an observation. 
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Figure.3.17.  characterisation of the C-terminal mutants 
L929 cells were were either induced or uninduced with 200 U/ml IFN-, or transfected the respective constructs with 
FuGENETM 6 reagent. 24 h post induction/ transfection, cells were lysed under hypotonic buffer conditions, and the 
post-nuclear supernatant and pellet were subjected to SDS-PAGE and western blotting. 
 
 
 studies on these mutants were therefore carried out to understand the importance of the C-
terminal region of IIGP1. Immunofluorescence studies, as described above (figure 3.10) show the 
typical reticular stain of the ER in case of the latter two, but is not evident in the former, leading to 
certain accumulations in the perinuclear region. This confirms the nature of IIGP1-his to be again 
different from IIGP1m and IIGP1wt. When the cellular distribution of both the proteins were 
analysed, both IIGP1-m and IIGP1-his show the differential distribution between the soluble and 
the membrane bound forms showing accordance with the transfected IIGP1-wt and the endogenous 
(IFN- induced) IIGP-1. The additional N-terminal myristoylation (Nm) mutant of IIGP1-m and 
IIGP1-his clearly shows a shift from the membrane to the soluble form as IIGP1-Nm described in 
figure 3.17.  
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Figure.3.18. Localisation of the C-terminal mutants, IIGP1-m and IIGP1-his. 
L929 cells grown on cover slips, and were transfected with the respective mutants for 24 h with FuGENETM 6 reagent. 
The cells 24 h post transfection were fixed with 3% paraformaldehyde, and permeabilised with 0.1% saponin and 
stained with  10D7antibody, and used Alexa 546 coupled secondary antibody. The staining was analysed with an 
Axioplan II fluorescence microscope, a cooled CCD camera and the pictures are processed using the Metamorph 
software. 
 
This confirms the influence of myristoylation on the membrane attachment of IIGP1. However, the 
additional G2V mutants of  IIGP1-m and IIGP1-his are predominantly membrane bound indicating 
no influence of nucleotide binding. Additionally, localisation studies also comply with the 
fractionation studies, where the myristoylation mutants show a  diffuse, cytosolic stain in 
comparison to the wildtype as shown in the upper panels (IIGP1-m and the additional 
myristoylation mutant ) and the lower panels ( IIGP1-his and the additional myristoylation mutant) 
in the figure 3.18. Rather, myristoyl modification seems to be modulating the IIGP1 localisation. 
Also, size exclusion chromatography of the unmyristoylated IIGP1 always runs as a monomer (data 
not shown). 
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III.B.4.3. Myristoylation independent association to the membrane 
 
A significant fraction of IIGP1 is membrane associated. Myristoylation has been shown to 
be important for the membrane association of IIGP1, although not solely (figure 4.5 and figure 
3.16). Therefore the properties of membrane binding of demyristoylated IIGP1 was analysed. L929 
cells were either induced with 200 U/ml IFN-, or transfected with the respective constructs with 
FuGENETM 6 reagent. 24 h post induction/ transfection, the cells were lysed in a hypotonic buffer. 
The distribution of endogenous IIGP1 is consistent being mostly membrane bound and partly 
soluble (upper panel, hypotonic supernatent, lane 2) as shown in figure 3.19. The membrane bound 
fraction of IIGP1 was solubilised with a high salt (lane 3), and then a high pH buffer (lane 4).  
Interestingly, a small fraction of the protein is solubilised under high salt (750 mM NaCl 
supernatent), and also in a high pH buffer (Na2CO3S supernatent) as shown. This suggests that the 
membrane association of IIGP1 is dependent on protein-protein interactions. Still, a considerable 
amount of the protein is intact, on the membrane (Na2CO3S pellet, lane 5).  
 
The same experiment was repeated for the IIGP1-Nm mutant, which is mostly cytosolic (IIGP1-Nm 
panel, lane 2). Interestingly, there is a significant proportion of the protein still bound to the 
membrane. This suggests another means of membrane association of IIGP1, apart from 
myristoylation and ionic interactions. IIGP1-his on the other hand, has a significant portion of the 
protein that is membrane bound, and some of them are solubilised with a high salt wash, and a high 
pH wash, but a significant portion is intact on the membrane. This is possibly the myristoylated 
IIGP1-his, and another fraction whose mode of membrane attachment is not known; unless the 
cysteine residue at the C-terminal end -CLRN- is subjected to lipid modification. The LRG-47 is 
used as a control for this experiment where it shows very tight membrane binding, and is resistant 
to a high salt/ high pH wash. This proves that apart from myristoylation, there are other features 
that allow membrane binding of IIGP1, mediated by protein-protein interactions, or other protein-
lipid interactions. 
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Figure 3.19. Membrane association of IIGP1. 
L929 cells were either induced or uninduced with 200 U/ml IFN-, or transfected with the respective constructs (IIGP1-
Nm, IIGP1-his) with FuGENETM 6 reagent. 24 h post induction/ transfection, cells were lysed under hypotonic buffer 
conditions, and the insoluble membrane pellet was first washed with 750 mM NaCl, and further washed with Na2CO3S- 
pH 11, and the pellets were subjected to SDS-PAGE and western blotting. Lane 1 contains the hypotonic lysate; 
hypotonic treated supernatent in lane 2;  hypotonic pellet solubilised with high salt in lane 3, salt insoluble pellet treated 
with high pH (11) showing a small soluble fraction in lane 4 , and the still membrane bound protein in lane 5. The first 
panel shows the distribution of IIGP1 in IFN- induced cells, followed by transfected IIGP1-Nm and transfected 
IIGP1-his detected with  10D7 antibody.  LRG-47 (member of the GMS subfamily) in IFN- induced cells is used as 
a control, and was detected with  LRG47 antiserum. 
 
 
 
 
 
 
 
 
 
 61
IV. RESULTS II  
9010  	 !)  '  !1 !$
 
IV.A.1.Crystal Structure of IIGP1 
Full length IIGP1 crystals diffracted to 2.1 Å resolution. The structural determination of 
IIGP1 was done by Dr. Eva Wolf. The crystals belong to the orthorhombic space group P212121 
and contain two molecules per asymmetric unit (figure 4.1). The IIGP1 molecule has two domains, 
the globular GTPase domain and a helical domain. The helical domain contains 10 helices, first 
three helices form the N-terminal region (dark grey), followed by the G-domain (fluorescent green), 
and last seven helices form the C-terminal region (orange). A linker helix connects the G domain to 
the C-terminal helical regions (cyan). The topology of the G domain is identical to Ras 
(Wittinghofer and Pai, 1991).  
 
 
 
 
Figure 4.1. Nucleotide free structure of IIGP1 showing the N-terminal helical region (dark grey) followed by the 
G.domain (fluorescent green) continuing to form the c-terminal helical region (orange). The linker helix connecting the 
G-domain with the c-terminal helical domain is shown in cyan. 
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The G domain consists of a 6 stranded -sheet of mixed topology with five parallel and one anti-
parallel -strand, which is surrounded by five alpha helices, a short 310 helix and several loop 
regions. In comparison to Ras, the IIGP1 molecule has a 13 amino acid insertion (residues 190-201) 
in the G domain. 
 
The two IIGP1 molecules have two dimerisation interfaces. Interface 1 involves knobs into holes 
side chain interactions between two N-terminal helices, and Interface II is characterised by a 
remarkable surface complementarity resulting from reciprocal hydrophilic and hydrophobic 
interactions between the G domain. Dimerisation leads to the formation of a prominent roundish 
hole with a diameter of roughly 20 Å. The lower part of the hole is formed by the GTPase domain, 
whereas the upper part of the hole is formed by the N-terminal helices. The roundish shape of the 
hole suggests a clamp-like function of the dimer, e.g as shown for several DNA- binding proteins 
(Brino et al., 2000; Ghosh et al., 1995). However, the walls of the hole are not positively charged. 
The electrostatic surface potential of IIGP1 reveals a polar distribution of charges with a cluster of 
negatively charged residues polarised on either sides of the dimer. This could be a potential effector 
binding site. The best structural homologues of the GTPase domain of IIGP1 from the PDB 
databank are EF-Tu, Ras and Arf1.  
 
IV.A.2.Features oftheIIGP1-GDP and the IIGP1-GppNHp Complex Structure 
The crystals of the GDP and GppNHp complex of IIGP1 diffracted to 2.0 and 2.7 Å 
respectively. The structures were solved by molecular replacement using the refined structure of 
nucleotide-free IIGP1 as a search model by Agnidipta Ghosh. These two complex nucleotide 
structures have similarities in their G domain to the nucleotide bound structures of Ras, Arf, Ef-Tu, 
-subunit of G protein and SRP. From the complex structures, the five GTP binding motifs were 
identified; G2 and G5 were revealed from the nucleotide bound structures; G1, G3, and G4 were 
already evident from the primary sequences (Bourne et al., 1991) as shown in figure 4.2A. The G2 
motif in IIGP1 is within the switch I region, identified as Thr 108, corresponding to Thr 35 of Ras 
and the G5 motif  231 SNK 233 has been identified as an additional base binding motif corresponding 
to the SAK/L of small GTPases. 
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Figure.4.2A. GTP binding motifs of IIGP1 
A. The nucleotide binding motifs are highly conserved among GTPases. Firstly, the phosphate binding loop,  (P-loop) 
which has the characteristic GETGSGKS for IIGP1, and two regions switch I (G2) and switch II (G3) whose sequences 
vary between, and to a lesser extent within small GTP binding protein families. The specificity of the nucleotide is 
derived by N/TKXD motif, and the SNK motif, an additional base binding motif is described from the nucleotide 
bound structure. 
 4.2B 
 
 
Figure.4.2B. IIGP1-GDP/GppNHp structure 
The canonical  GTP binding motifs (G1-G5) are described in the figure. The IIGP1-GDP structure is shown in red, 
superimposed with the IIGP1-GppNHp structure shown in green. 
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The nucleotide free IIGP1 structure and the IIGP1-GDP structures upon superposition do not show 
major differences and deviations in the overall structure. But the IIGP1-GDP and IIGP1-GppNHp 
structures do have some differences mainly in the G-domain as shown in figure 4.2B. All the GTP 
binding regions superimpose perfectly except for the conformation in the switch I region which 
moves away from the nucleotide binding site, as shown in the figure 4.2B.  

90"0  !1 !$

Nucleotide binding parameters are very crucial, as they modulate the function of GTPases. 
In order to obtain nucleotide binding deficient and GTP hydrolysis deficient mutants, point 
mutations were introduced in the phosphate binding loop (P-loop) of the protein, which abolished 
binding or hydrolysis in other GTPases (Chung et al., 1993). The mutations were introduced in the 
G1 motif, 76GETGSGKS83 of  IIGP1 and were called G2V (G76V / G81V), and K82A as depicted 
in the Table 3. G12V of Ras forms a constitutively active, oncogenic Ras (corresponding to G76 of 
IIGP1), and the K82A mutants show deficiency in nucleotide binding in other GTPases (Pai et al., 
1990). 
The crystal structure of IIGP1 shows two molecules related by a two fold non-crystallographic 
symmetry axis (figure 4.3 A,B,C,D showing the interface contacts). They share two dimer 
interface, interface I formed by the N-terminal domain and interface II formed by the two G-
domains of the IIGP1 molecules. Based on the distance between the two molecules in both the 
interfaces, potential residues were mutated with a criterion to de-stabilise the dimer interfaces. Two 
G domain interface mutants were designed. The side chain oxygen of Ser172 is stabilised by 
intramolecular interaction with the backbone nitrogen of Met173, and also by intermolecular 
interaction with the side chain sulphur of Met173 from another molecule as shown in figure 4.3A. 
Met173 in turn is stabilised by the hydrophobic pocket created by the hydrophobic residues (Phe, 
Ile ) from the corresponding molecule as shown in figure 4.3B. The Ser172 residue was replaced by 
Arg, thereby a steric mutant. The Met173 was replaced by Ala which is likely to destabilise the 
dimer by creating two (reciprocal) cavities. 
 
In the N-terminal interface, another steric mutation was introduced, Leu 44 to Arg. Leu44R 
interacts with itself forming hydrophobic interactions between the side chains. The carbonyl 
oxygen of Leu44 contacts the backbone nitrogen of Lys46 with a distance of 2.74 Å.  
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. 
Figure.4.3A.  
Ser172 and Met173 - The side chain oxygen (red) of Ser172 in molecule 2 is stabilised by intramolecular interaction 
with the backbone nitrogen (blue) of Met173, and also by intermolecular interaction with the side chain sulphur 
(yellow) of Met173 from molecule 1 as shown in figure 5a.  
 
 
 
 
 
Figure.4.3B. 
Met173 - The Met173 of molecule 1 in turn is stabilised by the hydrophobic pocket created by the surrounding 
hydrophobic residues (Phe, Ile ) of molecule 2 as shown by the white lines figure 5b. 
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Figure.4.3C and D  
Leu44, Lys48 - Leu44R interacts with itself forming hydrophobic interactions between the side chains.  
The carbonyl oxygen of Leu44 contacts the backbone nitrogen of  Lys48 with a distance of 2.74 Å. 
 
 
 
 
Figure.4.3E.   
Lys48 - The side chain nitrogen (blue) of Lys48 of molecule1 interacts with side chain oxygen (red) of Ser from 
molecule 2. The distance of this salt bridge is found to be 3.53 Å 
 
Lys 48 was replaced by either Ala or Glu. K48A probably eliminates a salt bridge in the helical 
dimer interface, thereby weakening dimerisation. K48E, seems suggestive of making alternative  
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salt bridges and seems like a mild destabilisation in the dimer interface. Also, a  double steric 
mutant L44R/ S172R (L/S) was also designed which is believed to dissociate the dimers. The 
figures dealing with the IIGP1 structure were made by Agnidipta Ghosh.  
 
IV.B.1. Biochemical Features 
 
The mutants were expressed as GST fusion proteins. The proteins were purified as 
described in Materials & Methods. Recombinant purified proteins are nucleotide free and are stable 
in the absence of nucleotides. 
 
IV.B.1.1. Analysis of the binding  mutants 
 
  
 mGTP mGDP 
 
 
GETGSGKS 
9 
 
Not done 
 
 
- No binding - 
 
 
GKS 
61 
 
- No binding - 
 
 
0.69µM 
 
 
- No binding - 
 
 
 
 
15µM 
 
 
 
 
 
 
TKVD 
64
 
 
mXppNHp : 55µM 
 
 
 
mXDP : (0.07µM) 
 
 
Table 4.1. Nucleotide binding affinities of the mutants to mant labelled guanine and xanthine nucleotides.   
 
The nucleotide binding properties of the p-loop mutants were analysed by stopped flow (Table 4.1). 
The G2V mutant did not show any mGDP binding. Since the G2V mutant did not bind mGDP, 
although IIGP1-wt has a 15-fold higher affinity to GDP than GTP, we supposed that this protein 
could not bind GTP either. Therefore the mGTP binding was not checked.  
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However, we analysed the GTPase activity of this mutant, and found its inability to bind GTP. In 
case of the K82A mutant, mGDP binding was similar to the wild type as shown in the table. 
Besides, it did not bind GTP. The Aspartic acid residue of the TKVD motif is responsible for 
guanine nucleotide specificity. Henceforth, we mutated the D186 to Asparagine (N). D186N which 
showed a 15-fold weak binding for mGDP in comparison to the wild type, as opposed to no binding 
for mGTP, and could not hydrolyse GTP. However, this mutation led to specificity for xanthine 
nucleotides (borrowed from Dr. J Reinstein), where it shows nanomolar affinity binding for mXDP, 
and low affinity binding to mXppNHp. The exchange of D for N has been shown to lower affinity 
for GTP and increase the affinity for XTP (Kang et al., 1994; Yu et al., 1997). The binding 
parameters for D186 residue of IIGP1 thus determines guanine nucleotide specificity, as described 
for the other GTPases  
 
IV.B.1.2. Analysis of the Interface Mutants 
 
IV.B.1.2.1. Analysis of the Nucleotide Binding Parameters of the Interface Mutants  
The nucleotide binding affinities of the interface mutants are very similar to IIGP1-wt as 
shown in Table 4.2, thereby implying that interference with the dimer interface does not hamper 
nucleotide binding properties 
 
IV.B.1.2.2. Studies on GTP Hydrolysis 
To study the influence of these mutations on GTP hydrolysis and cooperativity, the GTPase 
activity of all the mutants were measured. The interface mutants hydrolyse GTP to GDP as the 
wildtype, however all of them fail to show co-operativity displaying disparity with the wildtype as 
shown in the figure 4.3. IIGP1-wt shows an eight fold increase in the specific activity with increase 
in protein concentration (0.1- 0.8 min-1). Distinctly all the mutants fail to display cooperativity, and 
have a specific activity of 0.04 – 0.1 min-1 with the exception of K48E, showing a modest increase 
in activity with increase in concentration of the protein (0.3 min-1). The G domain interface mutants 
S172R and M173A have the lowest activity of 0.04 min-1.  
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Table 4.2. Comparative nucleotide binding affinities of IIGP1 and the mutants.  
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Figure 4.3. Interface mutants have depleted cooperativity. 
GTPase activity was measured at 37°C, with 700 µM GTP and varying concentrations of the protein (2 µM – 100 µM) 
as shown above. The interface mutants do not show co-operative mechanism of GTP hydrolysis like the IIGP1 wt 
protein (black filled circles), but is in accordance with the IIGP1 his (dark green circles) as shown in the figure. 
 
IV.B.1.3.  Characterisation of the IIGP1 Mutants 
As shown in figure 4.3 (above), interfering with the interface mutants resulted in abrogated 
co-operativity. Therefore to understand the cellular behaviour, all the interface mutants were 
subjected to cell biological characterisation. They were cloned into an eukaryotic expression vector 
pGW1H (Materials & Methods, and were characterised with respect to their localisation and 
distribution, upon transfecting these constructs to L929 fibroblasts. 
 
IV.B.1.3.1. Cellular Localisation of the Binding and the Interface mutants 
The interface mutants were transiently  transfected into L929 cells by lipofection and 24 h 
post transfection, the cells were analysed by immunofluorescence studies with IIGP1 specific 
10D7 antibody. Some important features were evident from the localisation studies of these 
mutants as shown in figure 4.4. The features that seemed obviously distinct are the ring around the 
peri-nuclear region (like IIGP1-his), the dotted pattern as described for the transfected IIGP1 wt, 
and the regular reticular stain of the ER. L44R, S172R, M173A, and the L/S mutant had phenotypes 
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typically observed for the IIGP1-his, and none of them show cooperative GTPase activity. The 
K48A and the K48E mutant looked more like the transfected IIGP1-wt pattern (K48A showed no 
cooperativity as opposed to moderate cooperativity in the case of K48E).  To conclude, all the 
mutants have distinct features in their cellular localisation. In comparison to the wild type. Co-
localisation studies would be helpful in the identification and the characterisation of these features. 
 
 
L44R K48A K48E
S172R M173A L44R/S172R
 
 
Figure.4.4. Localisation of the Interface mutants in L929 cells 
L929 cells grown on cover slips, and were transfected with the respective mutants for 24h with FuGENETM 6 reagent, a 
multiple component lipid based transfection reagent. The cells 24h post transfection/induction were fixed with 3% 
paraformaldehyde, and permeabilised with 0.1% saponin and stained with a10D7antibody, and used Alexa 546 coupled 
secondary antibody. The staining was analysed with an Axioplan II fluorescence microscope, a cooled CCD camera 
and the pictures are processed using  metamorph software.  
 
 
IV.B.1.3.2. Distribution of the Binding and the Interface mutants 
IIGP1 has  differential distribution in the cell, mostly membrane bound and partly in a 
soluble form as shown in figure 3.10. In order to analyse the influence of nucleotide binding, 
hydrolysis and the effects of the interface mutants on the differential distribution of IIGP1, cellular 
fractionation studies were carried out (figure 4.5). The binding mutants and the interface mutants  
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were transfected to L929 fibroblasts. 24h post-transfection, the cells were subjected to hypotonic 
lysis, the soluble and membrane forms were separated and subjected to SDS- PAGE and western 
blotting with the 10D7 serum as shown in the figure. The endogenous IIGP1 is consistently shown 
in the soluble and membrane bound form, the transfected IIGP1 wt and IIGP1-his also shows a 
similar distribution.  
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Figure. 4.5. Cellular distribution of the interface mutants 
L929 cells were either induced or uninduced with 200 U/ml IFN-, or transfected with FuGENETM 6 reagent. 24 h post 
induction/ transfection, cells were lysed under hypotonic buffer conditions, and the post-nuclear supernatant and pellet 
were subjected to SDS-PAGE and western blotting. IIGP1-Nm mutants is the myristoylation mutant, the description for 
which is included in the section III.B.4.1.  
 
 
The nucleotide binding mutants K82A and G2V, does not show any affect in their membrane 
attachment in comparison to the wild type, although they have defect in the nucleotide binding 
properties (the former deficient for GTP binding and the latter for GTP as well as GDP binding). 
Additionally, all the dimer interface mutants (L44R, K48A, K48E, S172R, M173A, L/S) without 
any exception, can still bind to the membranes as the wild type. This indicates that neither 
nucleotide binding nor interference with the dimer interface interferes with the membrane 
attachment of IIGP1. 
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V. DISCUSSION 

This study encompasses biochemical, structural and cellular studies on IIGP1. The 
biochemical characterisation focuses on understanding the properties of IIGP1 as a GTPase. 
GTPases modulate diverse functions by binding to a variety of effectors and regulators in the 
different nucleotide states (Bourne, 1991). In comparison to other GTPases, the properties of IIGP1 
with respect to the nucleotide binding parameters, hydrolytic mechanism and structural features are 
analysed.  
 
V.1. Nucleotide Binding Parameters of IIGP1 in Comparison to Several GTPases 
   
To position IIGP1 in the context of the other GTPases, a comparative analysis of their properties 
are tabulated (table 5.1). The family of small GTPases has a very high affinity for nucleotides, and 
are stable only in the presence of nucleotides. IIGP1, on the other hand has very low nucleotide 
affinities (micromolar Kd value) and is stable in the absence of nucleotides. Therefore IIGP1 is 
grouped with the large GTPases, the dynamins, hGBP1 and Mx GTPase which have very low 
nucleotide affinities and are also stable in the absence of nucleotides. However dynamin and Mx 
exist as oligomers in solution (Danino and Hinshaw, 2001; Haller and Kochs, 2002). Additionally, 
the nucleotide free IIGP1 structure and the IIGP1-GDP structures upon superposition do not show 
major differences and deviations in the overall structure. The regions which undergo alteration 
upon nucleotide binding are designated as switch regions (switch I and switch II) in the small 
GTPase family (Vetter and Wittinghofer, 2001). The stability of the switch regions in the 
nucleotide free IIGP1 structure and the IIGP1-GDP structures presumably explains the stability of 
the protein in solution.  
IIGP1 has higher affinity for GDP than for GTP (15-fold) as listed in table 5.2 and therefore may be 
considered EF-Tu like in this respect. Ras and EF-Tu have very slow nucleotide dissociation rates 
(table 5.2). Both of them bind GDP very tightly (pM and nM Kd values) and therefore the GDP 
release is regulated by the guanylate exchange factors (GEFs), Sos and EF-Ts respectively 
(Gromadski et al., 2002; Boriack-Sjodin et al., 1998; Chardin et al., 1993). The guanylate exchange 
factors function by increasing the dissociation rates. The dissociation rates for IIGP1 are very high, 
21 s-1 for GTP and 3.6 s-1 for GDP. This indicates a very short life span for the complexes as 
compared to Ras-like GTPases, G or EF-Tu. The GEF catalysed GDP dissociation rates of Ras 
and EF-Tu are comparable to the intrinsic dissociation rates of IIGP1 as shown in table 5.2. 
Therefore, guanylate exchange factors (GEF) do not seem to be necessary to promote activation of 
IIGP1 through replacement of GDP with GTP. This is also supported by structural observations 
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where the GDP-IIGP1 structure already mimics a GEF bound conformation. Therefore we presume 
that GEF is not necessary for IIGP1. Given the nucleotide binding properties of IIGP1 and the 
relative cellular concentrations of GTP (90 %) and GDP (10 %), the molar ratio of the GDP and 
GTP states should be close to one. Here, we can only speculate about a shift in the relative 
populations invoked by a potential interaction partner, which might change the relative affinities of 
GDP and GTP. 
 
 
Table 5.1. Summary of the comparative nucleotide binding affinities in GTPases (upper panel) and the lower panel 
shows the GTP versus GDP affinities. (Similar means less than 5 fold difference and higher means more than 10 fold). 
 (Binns et al., 1999; Binns et al., 2000; Eccleston, 1984; Eccleston et al., 2002; Gromadski et al., 2002; John et al., 
1990; Klebe et al., 1995; Richter et al., 1995; Romero et al., 1985). 
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Table 5.2. Features of nucleotide binding and hydrolysis in GTPases. 
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V.2. Significance of GTP Hydrolysis 
 
The GTPase activity has been shown to be crucial for the regulation of almost all GTPases. 
The GTPase superfamily can be described as switch GTPases, the GTP bound form interacting with 
downstream effectors, which dissociate upon GTP hydrolysis. The time from the binding of GTP to 
the hydrolysis is critical for downstream cellular functions and is therefore targeted for precise 
modulation. For example, Ras has a low hydrolytic rate (0.02 min-1). Here, functional efficiency is 
achieved by accelerating the turnover rate by a factor of 105 by an activating protein RasGAP 
(Scheffzek et al., 1997; Ahmadian et al., 1997). The GAPs negatively regulate cell signalling by 
increasing the slow intrinsic GTP to GDP hydrolytic rate. The lowest hydrolytic activity of IIGP1 
was documented as ~ 0.1 min-1, the highest documented is 2 min-1 under saturating conditions. In 
comparison with the GTPase activity of several GTPases from the table, IIGP1 can be placed 
somewhere between the small and the large family of GTPases. The activity looks more similar to 
G (Tesmer et al., 1997) than other GTPases. Therefore the query is, if IIGP1 needs a GAP, and 
whether a internal or an external GAP. 
The GAP stimulated GTPase mechanism is conserved among the Ras family of GTPases; Rho/ Ras/ 
Rabs/ Ypts/ Ran/ Arfs (Vetter and Wittinghofer, 2001; Takai et al., 2001). GTP is hydrolysed by an 
attack on the  phosphate by a nucleophilic water molecule. GAP interacts with the GTPase and 
reduces the flexibility of the switch regions. For e.g GAP-334 of Ras has an arginine residue 
pointing into the nucleotide binding site and neutralising the negative charges of the  and  
phosphates. Over and above, it anchors Gln 61 of the switch II region which stabilises the water 
molecule. This is called the arginine finger and a secondary positively charged residue stabilises 
this finger loop. Therefore, Gln61 at the amino-terminus of switch II is the residue that abstracts the 
proton from the attacking water molecule (Scheffzek et al., 1997; Scheffzek et al., 1998; Mittal et 
al., 1996; Ahmadian et al., 1997). Besides, the regulators of G protein signalling, the RGS proteins 
accelerate G catalysed GTP hydrolysis to nearly a 100-fold with a similar priniciple, with the 
exception of the intrinsic catalytic arginine residue (De Vries and Gist, 1999). This residue is 
provided by the helical insertion of the G protein itself as shown in figure 5.1, and the RGS proteins 
are apparently needed only to stabilise the switch regions in conformations that are complementary 
to the transition state (Coleman et al., 1994; Sondek et al., 1994). In short, Ras has an external GAP 
and G has an internal GAP.  
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Figure 5.1.  The stabilising arginine finger is supplied in -trans in the case of Ras/Rho superfamily, and -cis in the case 
of G  proteins (Scheffzek et al., 1998). 
 
Sequence analysis shows that IIGP1 has a Ile in the place of Gln61, suggesting some variation in 
the catalytic mechanism in comparison to the Ras family of GTPases. All the members of the large 
family of GTPases, the dynamins, Mx and hGBP1 also have a hydrophobic residue as in IIGP1 
(Prakash et al., 2000), implicating a different catalytic mechanism from the small GTPases. 
Interestingly, we could not detect any AlFx binding to IIGP1-GDP like Ras (Mittal et al., 1996), 
again suggesting the need for an activating protein, since binding of AlFx to the small GTPases in 
the GDP-bound state has been shown only in the presence of a GAP. AlFx essentially plays the role 
of the leaving  phosphate and mimics the transition state of GTP hydrolysis. The lack of binding of 
AlFx to IIGP1-GDP may be due to the relatively strong binding of GDP itself, in comparison to the 
GTP bound state or the transition state, thereby not needing AlFx to stabilise the interaction. Yet, 
another explanation may be the unavailability of a GAP crucial for stabilizing the transition state 
analogous complex IIGP1-GDP-AlFx. Recently, AlFx binding to hGBP1-GDP (hGBP1 is a 67kDa 
interferon induced GTPase) in the absence of an external GAP has been documented (Praefcke et 
al., 1999). In the interests of consistency, this result can be explained by the proposition that hGBP1 
might have an internal GAP domain like the G. This suggests that IIGP1 would need a GAP to 
accelerate the GTP hydrolysis, and unlike hGBP1 might be an external GAP, and probably a 
different mechanism than the small GTPases. In contrast, the argument towards an internal GAP is 
also plausible as IIGP1 shows increase in activity with increase in the concentration of the protein, 
conforming to the family of large GTPases. 
However, an exception among the small GTPases is the Rho family. Certain members of the Rho 
family GTPases e.g Rho A, Rac2 and Cdc 42Hs form reversible homodimers under physiological 
buffer conditions   and  . Intriguingly the presence of a  C-terminal polybasic motif 
located N-terminal to the isoprenylation CAAX isoprenylation sequence correlates with the 
homotypic interaction of Rho family members. Besides a built-in arginine finger has been shown to 
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confer a self-stimulatory GAP activity through homotypic interactions (Zhang et al., 2001; Zhang 
and Zheng, 1998; Zhang et al., 1999). There are polybasic residues in the c-terminal end of hGBP1, 
but is not apparent in Mx, Dynamin and IIGP1. 
 
V.3. Relationship of IIGP1 to the Family of Dynamin like large GTPases  
 
 To note the similarities and differences in the properties of IIGP1 to the members of the 
dynamin family, the characteristic features of three representative GTPases are compared. 
Dynamins are large GTPases (~100kDa), essential for vesicle formation in receptor mediated 
endocytosis, synaptic vesicle recycling, caveolae internalisation and vesicle trafficking (Danino and 
Hinshaw, 2001). Mx (~ 80kDa) and hGBP1 (67kDa) are dynamin family members, and are most 
abundantly expressed in response to interferons (Haller and Kochs, 2002; Praefcke et al., 1999; 
Schwemmle and Staeheli, 1994). hGBP1 is shown to block the replication of several viruses 
(Anderson et al., 1999), and the Mx proteins exhibit strong antiviral activity. 
IIGP1 differs from this family of GTPases (Dynamin/Mx/hGBP1) having high GDP affinity (15-
fold) and low GTPase activity (2 min-1 under saturating protein conditions, see table 5.2). There is 
no sequence homology between IIGP1 and Dynamin /Mx/ hGBP1 proteins outside the G domain. 
(Mx and dynamins share a low sequence homology). Although there are many variations in the 
structural features, Mx and dynamins possess a N-terminal GTPase domain of ~ 300 residues, a 
middle or assembly domain (150-200 residues) and a GED domain (100 residues) (Urrutia et al., 
1997). These domains correspond to the LG domain, helical bundle, and 12/13 domains of hGBP1 
respectively (Prakash et al., 2000). IIGP1 also has a N-terminal G domain, as well as the C-terminal 
helical regions (figure 5.2). 
There exist many analogous features in the dynamin family like the low nucleotide binding 
affinities and higher nucleotide dissociation rates (table 5.2). The distinctive feature of this family is 
that none of  the four members has a glutamine residue in the switch II region. IIGP1 shares the 
property of cooperative GTPase activity (figure 3.7) with the members of this  family. This 
indicates a different functioning from the small GTPases, but a common mechanism for this family 
of GTPases. An internal GAP for all the three GTPases has been suggested, since self assembly 
leads to increased GTPase activity. It was concluded that the GED domain in dynamin supplies a 
catalytic arginine residue acting as an assembly dependent internal GAP when the isolated GED 
domains were added in 	 to the G domain of dynamin (Sever et al., 1999), as the C-terminal 60 
residues are required for the GTPase reaction of Mx (schwemmle et al., 1995). In hGBP1, an 
arginine from the p-loop suggested to have a catalytic role (Prof.Christian Herrmann, personal 
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communication). This suggests that the self assembly is an important feature in this family of 
GTPases. In addition, another layer of regulation is mediated by the nucleotide dependence of the 
self assembly process which is observed in all the members of this family. 
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Figure 5.2. Secondary structure analysis of the large family of GTPases 
The dynamin family possess specific domains that perform distinct functions. A highly conserved tripartite GTP 
binding domain at the N-terminus followed by a membrane binding pleckstrin homology domain (PH ), the GTPase 
effector domain (GED) to activate dynamin GTPase activity and the  proline rich domain demonstrated to interact with 
numerous other proteins. Mx proteins have the N-terminal globular G domain containing the tripartite GTP-binding 
motifs and the self assembly domain (SAD).  The C-terminal effector region comprises the central interactive region 
(CID) and the leucine zipper region (LZ). hGBP1 has the N-terminal globular domain followed by the helical bundle, 
and the two c-terminal helices make a coiled-coil structure (  12-  13). IIGP1 also contains an N-terminal G domain 
followed by a helical domain though there is neither sequence nor structural similarity to any of the other GTPase 
families 
 
 
 V.4. Nucleotide Dependent Self Assembly 
 
The characteristic feature of the family of large GTPases is their ability to self-assemble into 
defined structures. This has been well documented in dynamin and Mx. For example, dynamins 
 form rings or stacks (Carr and Hinshaw, 1997; Hinshaw and Schmid, 1995), and into helices 
and spirals around the necks of clathrin coated pits   (Takei et al., 1998). These rings and 
helices have the same dimensions as the electron dense collars formed by the temperature sensitive 
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dynamin mutant 	-.
in ,	- 
	
. Assembly of dynamin is favoured by low 
ionic strength, GTP analogues, GDP in combination with  phosphate analogues and acidic lipid 
membranes (Carr and Hinshaw, 1997; Hinshaw and Schmid, 1995; Stowell et al., 1999; Klockow et 
al., 2002). Assembled dynamin on a lipid tube underwent fission upon GTP hydrolysis, thus 
behaving like a molecular motor (Sweitzer and Hinshaw, 1998). Additionally, dynamin mediates 
tubular-vesicular complexes in cells or in cell-free assays (Hinshaw, 1999; Hinshaw, 2000; 
Thompson and McNiven, 2001). The membranes from hypotonically lysed rat brain synaptosomes 
incubated with rat brain cytosol and GTPS could support the formation of tubular invaginations 
decorated with dense staining rings of dynamin(Takei et al., 1998; Takei et al., 1999). Therefore 
mechanochemical models for the action of dynamins are based either on constriction as discussed 
above or stretching of the helix (Kozlov,1999). This function of dynamin has been challenged by 
the suggestion that GTP-bound dynamin activated downstream effectors (Sever et al., 1999, 2000). 
However recent studies show that GTP hydrolysis and an associated conformational change is 
required for endocytosis, supporting a mechanochemical function for dynamin (Marks et al., 2001).  
A critical and unresolved issue is whether the interferon inducible GTPases behave as conventional 
GTPases or as mechanochemical enzymes. 
 
Mx proteins like the dynamins interact with lipid membranes which become deformed by the 
formation of structured oligomers. They assemble into regular rod and ring like structures, and can 
bind and tubulate lipids  (Accola et al., 2002; Melen et al., 1992; Di Paolo et al., 1999), and 
the structures are also nucleotide dependent (Accola et al., 2002; Nakayama et al., 1993; Kochs et 
al., 2002).  Mx associates with smooth ER and is shown to alter the organelle morphology (Accola 
et al., 2002). Only in the GTP bound form, MxA associates with the nucleocapsids of thogotovirus 
by binding to the nucleoprotein component. This suggests that unlike dynamin Mx does not need 
GTP hydrolysis for its function (Haller and Kochs, 1999). An oligomerisation deficient mutant in 
Mx, did not show detectable GTPase activity but provided antiviral resistance against thogotovirus. 
It is therefore suggested that an intracellular pool of MxA is maintained in the oligomeric form. 
Upon GTP hydrolysis, monomers are released from such oligomeric structures from which 
antivirally active monomers could be recruited over prolonged periods of time (Janzen et al., 2000). 
But there is no direct evidence for the dispersal of the monomers upon GTP hydrolysis. In contrast 
Warnock., et al show the destabilisation of  assembled dynamin 1 structures with the addition of 
GTPS, GTP and GDP in the decreasing degrees of potency respectively. Only  studies have 
been done for the p67 GTPase hGBP1. The special feature of hGBP1 is that it binds GTP, GDP and 
GMP with similar affinity. hGBP1 is a monomer in the nucleotide free form and in the presence of 
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GDP. It forms dimer with GppNHp, and a still bigger size molecular form with GDP.AlFx (Prakash 
et al., 2000). On the other hand, the  significance of self assembly in hGBP1 has not been 
investigated. 
 
Dynamiclight scattering studies show that IIGP1 oligomerises only in the presence of GTP, and a 
time dependent increase in the size of particles is observed (Figure 3.8). Increased assembly is also 
seen in the case of Mx in the GTP bound form, but the significance of this property is unknown 
(Accola, 2002). Since oligomerisation in IIGP1 was possible only in the presence of GTP or 
GppNHp, and not in the presence of GDP, the reversibility of these oligomers was tested with 
respect to GTP hydrolysis. The self assembly process of IIGP1 was found to be a reversible 
process, upon GTP hydrolysis (figure 3.9). This suggests that GDP formation inhibits 
oligomerisation. The GDP is bound more tightly than GTP, and therefore a shift in the GDP-bound 
to the GTP-bound population mostly occurs, the former inhibiting and the latter favoring self 
assembly. IIGP1 is present as a monomer in solution, like hGBP1, wheras dynamin and Mx are 
always present as monomers, and could oligomerise without nucleotides. However, IIGP1 
crystallised as a dimer, without nucleotides or with GDP, although a monomer in solution. 
Therefore it may not be a very stable dimer (figure 4.1). Nonetheless, the two dimer interfaces are 
obvious from the structure. Interface I is formed between the N-terminal helices and interface II is 
formed between the G-domains. To check the importance of the dimer, several mutations were 
designed to investigate the influence of the dimer on the properties of IIGP1 (figure 4.3). Firstly, 
mutations presumably interfering with dimerisation had no effect on nucleotide binding as shown in 
table 4.2. Secondly, putative interference with the dimer interface led to abolished cooperativity in 
L44R, K48A, S172R, M173A, L44R/S172R mutations and reduced cooperative GTPase activity in 
K48E (figure 4.3). The cooperativity of K48E could be explained by the ability to form alternate 
interactions gaining stability. The nucleotide dependent oligomerisation has not been investigated 
for these mutants. The correlation between oligomerisation (if persistent) and abrogated 
cooperativity would give a better understanding of the different interface mutants.  
The cooperative activity and GTP dependent oligomerisation of IIGP1 are likely to be essential for 
regulating its function . There is some evidence that IIGP1 can form stable oligomers under 
 conditions. Size exclusion chromatographic analysis of induced IIGP1 cell lysates show that 
the soluble IIGP1 always fractionates as a monomer with a size of 47 kDa, and the membrane 
bound IIGP1 elutes as a 150 kDa complex (probably a detergent artefact). The components of this 
membrane bound complex could be either homomeric or heteromeric (figure 3.12). Since  
nucleotide dependent oligomerisation is evident, it is tempting to say that this complex is probably 
homomeric. Additionally myristoylation has been shown to push the protein towards aggregation. 
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The only clue for this speculation comes from the dissociation of the complex upon pre-treating it 
with 1% SDS solution. In these experiments, the interaction of the protein with detergents cannot 
be ruled out, as the Tx-100 series detergent, thesit, used for the size exclusion column runs has been 
documented to have a molecular weight of ~90 kDa at the critical micelle concentration. The 
molecular mass of the complex observed, fits to the size of the predicted components (micelle and 
IIGP1). On the other hand, if the ~150 kDa IIGP1 complex is heteromeric, then it would be 
interesting to identify the molecular partners of IIGP1. In this regard, co-precipitation studies for 
IIGP1 by metabolic labelling of IFN- induced L929 fibroblasts with  165 showed three potential 
interacting molecules (~ 100 kDa, ~ 25 kDa and a ~ 40 kDa). The added size of these molecules fits 
to the size of the complex (figure 3.14A). On the other hand, the three co-precipitating molecules 
were not observed in the Tx-114 detergent phase, although they were coprecipitated in the aqueous 
phase. This could be explained by the temperature shift in this experiment which could possibly 
destroy the complex. The short cut way to understanding the IIGP1 complex would be to identify 
the coprecipitated molecules. Furthermore, the monoclonal antibodies can also immunoprecipitate 
IIGP1, and the specific co-precipitation of IIGP1 partners is to be investigated. 
 
However IIGP1 is massively induced by IFN-  to at least 2x106 molecules per cell (Jia Zeng, 
unpublished results). Such an abundant protein (and IIGP-1 is only one of many p47 GTPases for 
which this argument will have to be made) may be retained in an inactive state with slow GTP 
hydrolysis, preventing its futile hydrolysis of GTP. On this argument IIGP1 may needs a regulatory 
signal, which could either be derived from pathogens upon infection, or from the host immune 
system itself for activation. IIGP1 has very high dissociation rate for GTP, and slow GTPase 
activity. Therefore it is likely to be present in the GDP form  . Thus activation of IIGP1 
probably means holding the IIGP1 in the GTP bound form, to be able to bind to pathogen 
components thereby arresting their propagation prior to their hide out in the intracellular 
membranes. The significance of the   GTP dependent homooligomerisation of IIGP1 in 
context to a pathogen has to be understood. It is clear from dynamins that self assembly is essential 
for their biological function, where the dynamin assembled around clathrin coated pits, clip off the 
vesicles, and dissociate the oligomers upon GTP hydrolysis. The significance of the self assembly 
of Mx on the antiviral activity is not understood. There is only one report showing the formation of 
protein complexes upon binding of MxA to the viral nucleocapsid protein of  La Crosse virus 
(LACV) suggesting that the oligomerisation of MxA is due to viral target recognition (Kochs et al., 
2002). On the other hand, no quantitative nucleotide binding parameters or cellular characterisation 
with respect to their nucleotide states is available for the p47 GTPases to make comparisons with 
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IIGP1.  
 purified IGTP was detectable only in the GTP bound form (Taylor et al., 1996), 
suggesting very low GTPase activity. With these studies, we cannot conclude whether IIGP1 would 
behave as a conventional GTPase or a mechanochemical enzyme like the dynamins. This is not 
clear for Mx or GBPs.   
 
V.5. Association of IIGP1 with Membranes 
 
The cellular IIGP1 is predominantly membrane-bound and partly cytosolic. The free 
cytosolic pool may be in equilibrium with the membrane bound material, although other scenarios 
are also possible. If the two pools are in equilibrium with each other, the equilibrium could be 
maintained by nucleotide binding and hydrolysis however the experiments reported here (figure 
4.5, table 4.1) argue against this idea. Thus, the nucleotide binding/hydrolysis deficient mutants 
(G2V, K82A) do not influence the equilibrium between the membrane and the soluble fractions of 
IIGP1. This also seems to be evident with the dimer interface mutants (L44R / K48A / K48E / 
S172R / M173A / L44R/S172R), which equally do not show any distinctive change in the 
distribution relative to IIGP1.   
When the glycine residue in the putative N-terminal myristoylation motif (MGQLFSS) was mutated 
to Ala (the mutant designated as IIGP1-Nm), a considerable shift of the membrane bound IIGP1 to 
the soluble form occurs (figure 4.5). Analysis of the IIGP1-Nm mutant by immunofluorescence 
showed cytosolic staining unlike wild type IIGP1 (figure 3.16). Similar results were obtained when 
the same experiments was done with the myristoylation mutants of IIGP1-m and IIGP1-his (table 
3.1) as shown in figure 3.17 and 3.18). This strongly supports a role of myristoylation in the 
membrane attachment of IIGP1, although perhaps not alone. The shift from the membrane to the 
soluble form is not complete, suggesting that demyristoylated IIGP1 can still interact with 
membranes. This would bring IIGP1 in line with IGTP or LRG47 which also interact with 
membranes even though they do not have a myristoylation signal. A small fraction of membrane-
bound demyristoylated IIGP1 could be washed off with a high salt and a high pH wash, suggesting 
the need of ionic interactions in the membrane binding of IIGP1. Besides, a small portion of the 
protein is still bound to the membrane irrespective of the above proposed interactions. This could 
be explained (see comment above) by the possibility of another additional lipid modification at the 
C-terminal. This has not been checked, although the extreme C terminal sequence IIGP1 has a 
CaaX like sequence (CLRN) Therefore we conclude that myristoylation and other ionic interactions 
are important for the attachment of IIGP1 on membranes. 
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V.6. Cellular Localisation 
 
Endogenous, interferon-induced IIGP1 shows a reticular ER distribution. However, 
transfected IIGP1 shows a somewhat variable appearance, often including apparent accumulations 
of  IIGP1, in addition to a more or less normal looking reticular stain (figure 3.10) and the typical 
reticular peri-nuclear ER stain. The identity of these accumulations is not known. The different 
features of the induced and transfected IIGP1 could mean that there is a influence of the IFN- 
response on the localisation of IIGP1. IIGP1-his, however, (table1, results partI) shows a different 
phenotype in comparison to the wild type.  studies of this C-terminal mutant show that it 
lacks cooperativity as a GTPase as well as nucleotide dependent oligomerisation, as shown in 
figure 3.7 and figure 3.8 respectively. Nonetheless, comparison of the nucleotide binding 
parameters of  IIGP1-wt and IIGP1-his show no difference (Table 2b). This indicates that IIGP1-his 
has a role in interfering with oligomerisation rather than shielding or delaying the GTP 
binding/hydrolysis, and also suggests the importance of the C-terminal. In contrast the properties of 
IIGP1-m with a different C-terminal modification (table 3.1) conforms to the wild type.  
 
The localisation data for the interface mutants (figure 4.4) showed phenotypes like the typical peri-
nuclear staining of the induced IIGP1 (L44R, S172R), a pattern of dots in addition to the reticular 
ER stain of  the transfected IIGP1-wt (K48E, K48A) or the re-organisation of the ER as in 
transfected IIGP1-his (L44R, S172R, M173A). Recently a similar observation was seen for a 
mutant of MxA (K83A, the P-loop lysine) which showed only slightly different distribution from 
the wild type by immunofluorescence, but a dramatic expansion of a membranous compartment 
apparently corresponding to the smooth ER was seen by electron microscopy (Accola et al., 2002). 
The phenotypes observed for IIGP1 and its mutants could give more insights into the function, and 
more information could be extracted by electron microscopy. 
Conclusively, studies on the membrane attachment of IIGP1 and the identification of the interaction 
molecules seem to be crucial to understand the function of IIGP1. Similar to the ER membrane 
distortions in IIGP1-his, re-organisation of the respective membranes has been shown for Mx and 
dynamins, as described above. Since these GTPases are associated with different intracellular 
membranes, and they are known to modulate membrane compartments, and share a strong 
relationship with respect to their biochemical features, it is possible that they all have a common 
mode of regulation.  
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V.7. Functional Cues for IIGP1 
 
The primary sequence of IIGP1 shows several clues for the derivation of the function. IIGP1 
has a F/YxxxxF/Y sequence (residue numbers) which is considered a strong endocytosis and 
putative AP2 binding motif. In addition to this sequence, a second motif which is a double 
phenylalanine motif (FF) residue when present together has been shown to bind sec 23 which is a 
part of the COP II coat (Dominguez et al., 1998). In addition, IIGP1 also has the di-acidic motif 
(DXE) which has been shown to bind to the sec23p-sec24p COPII sub complex, facilitating ER 
export (Votsmeier and Gallwitz, 2001). COP II is involved in ER to golgi transport by forming 
transport vesicles and segregating biosynthetic cargo from ER-resident proteins (Barlowe, 2002). 
Interestingly, only ER staining of IIGP1 was observed by immunofluorescence (Sascha Martens 
unpublished results) as opposed to both golgi and ER staining (Zerrahn et al., 2002) under the same 
conditions, and cell lines used. Further analysis is necessary to count for this discrepancy. 
 
V.8. IIGP1 in the p47 Family    
                                                                                                                                                                                    
IIGP1 is not constitutively expressed but is stimulated by IFN- which is an immune or 
inflammatory stimulus, therefore may probably prove to be a resistance factor against intracellular 
pathogens by analogy with its p47 relatives IGTP, TGTP, LRG-47 and IRG-47. A significant 
observation in three members of this family (LRG47, IGTP and GTPI), in addition to other shared 
sequence features, is a radical substitution in the P-loop from lysine (GKS) to methionine (GMS) 
which is unique only to this subfamily of GTPases (Sorace et al., 1995; Taylor et al., 1997b; Boehm 
et al., 1998). The lysine to methionine substitution is compatible with GTPase activity at least in the 
context of the p47 structure since the GMS p47 GTPases, IGTP and LRG-47 bind GTP and IGTP 
has been shown to hydrolyse GTP to GDP. Interestingly, 
 purified IGTP was detectable only 
in the GTP bound form (Taylor et al., 1996), suggesting slow GTPase activity. Unfortunately, no 
quantitative nucleotide binding parameters are available to make comparisons with IIGP1.  
The crystal structure of IIGP1 is a representative structure for the p47 family of GTPases. This 
conclusion arises firstly, from secondary structure analysis of other members of the family which 
are very similar to IIGP-1 and conform to the expectation derived from the crystal structure, and 
secondly from the conservation of several pairs of distant residues in other p47 family members 
which interact to stabilise the IIGP-1 structure. This conservation could not be explained unless the 
structures of the other p47 GTPases are very similar to IIGP-1. Structural analysis of IIGP1 with 
respect to the sequence comparison with the members show several conserved regions, forming the 
core regions. However large deviations in the primary structure between the members, especially at 
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the N and C termini suggests their non-redundancy as indicated by their distinct subcellular 
locations, and resistance to specific pathogens (Collazo et al., 2001; Halonen et al., 2001; Taylor et 
al., 1997; Taylor et al., 2000). 
 
V.9. Proposed Function 
 
Pathogens have developed several mechanisms to block and subvert normal cellular 
processes, thereby contributing to pathogenesis. They use and alter several cellular targets like the 
cytoskeletal network, signal transduction pathways and vesicle transport machinery for their 
propagation (Knodler et al., 2001). Many pathogens use the cellular membrane systems for creating 
a protected intracellular niche, securing themselves from the host immune system (Ploegh, 1998; 
Meresse et al., 1999). Since the p47 GTPases, including IIGP1 are associated with several 
intracellular membranes in the cell, it is a hypothesis that IIGP1 might be protecting the cell by 
interfering with the life cycle of specific pathogens. By doing so, it probably prevents the 
exploitation of the ER/Golgi membrane by the pathogens. Nothing is yet known about how the p47 
GTPases exercise their adaptive function.  
The studies presented here have given an insight into understanding IIGP1 as a GTPase, and show 
analogous properties to the dynamin family of GTPases. However, the structural features do not 
show any homology. It seems crucial to get a detailed view of the oligomerisation property of 
IIGP1   and   in order to understand its regulatory mechanism. Still, the nucleotide 
bound structures of IIGP1 (GDP and the GppNHp) do not give clues to the GTPase mechanism of 
IIGP1. A key task is now to identify the protein neighbours or regulators of IIGP1 in its native 
environment in the IFN- induced cell, in the present context especially to identify possible GAPs 
or other regulatory proteins. This could help us to couple the oligomeric behaviour of IIGP1 to its 
biological function. With respect to the biological significance of IIGP1, it is worthwhile to 
examine whether these regulatory molecules could be derived from the pathogens themselves or 
might be stimulated by the entry of the pathogen into the cell, mainly due to their expression only 
upon IFN- induction. 
 
The data described here formulates a platform for further analysis on IIGP1 function and provides 
essential parameters to understand the molecular mechanism by which IIGP1 participates in this 
complex resistance programme. The characterisation of IIGP1 has given an understanding to the 
behaviour and properties of the protein  and . 
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VII. SUMMARY 
 
My thesis work focuses on the biochemical, structural and cellular characterisation of IIGP1, a 
member of the p47 family of GTPases. 
 
The p47 family of GTPases are induced transcriptionally from very low resting levels in mouse 
cells by interferons and are implicated in cell autonomous resistance to intracellular pathogens. A 
vast subset of genes are regulated by IFNs and the mechanistic details of only a few have been 
described. Therefore, to understand the function and features of this family of GTPases, an in depth 
study on IIGP1, a member of this family is investigated. Recombinant IIGP1 was expressed in 
* and purified to homogeneity, and a detailed biochemical characterisation of IIGP1 was 
carried out. IIGP1 is a GTPase with low affinity for nucleotides (micromolar range) and a low 
GTPase activity. The GTPase activity is concentration dependent and functional interaction 
between IIGP1 molecules occur in a nucleotide dependent manner. IIGP1 shares micromolar 
nucleotide affinities, and oligomerisation-dependent hydrolytic activity with the 67 kDa GTPase 
hGBP1 (induced by type I and type II interferons), with the antiviral Mx proteins (type1 interferon 
induced) and with the paradigm of the self-activating large GTPases, the dynamins. Besides, IIGP1 
differs by having a high affinity for GDP and low GTPase activity. 
 
The crystal structure of IIGP1 has a N- terminal helical domain followed by a typical G- domain 
fold and C- terminal helical regions. IIGP1 structure is a representative structure for the p47 family 
of GTPases. This conclusion arises firstly, from secondary structure analysis of other members of 
the family which are very similar to IIGP-1 and conform to the expectation derived from the crystal 
structure. Secondly, from the conservation of several pairs of distant residues in other p47 family 
members which interact to stabilise the IIGP-1 structure. This conservation could not be explained 
unless the structures of the other p47 GTPases are very similar to IIGP-1. Structural analysis of 
IIGP1 with respect to the sequence comparison with the members show several conserved regions, 
forming the core regions. However large deviations in the primary structure between the members, 
especially at the N- and C- termini explains their non-redundancy as indicated by their distinct 
subcellular locations, and resistance to specific pathogens. 
 
Cellular characterisation of IIGP1 was investigated in order to understand the features of IIGP1 in 
the cell. Previous studies on IIGP1 has shown the association of IIGP1 with the endoplasmic 
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reticulum. Since the primary sequence does not indicate signal sequences, or ER retention or 
retreival signals, IIGP1 is rather peripherally associated with the ER. Cellular fractionation studies 
reveal differential distribution of the protein, present mostly in the membrane bound form and 
partly in the soluble form. Membrane attachment is dependent on myristoyl modification, although 
not solely. There is evidence for ionic interactions which could allow the association of IIGP1 to 
the membranes, and another pool of the protein is independent of the above two modifications for 
membrane attachment. This could be accomplished by the C-terminal CaaX like motif for IIGP1 
(CLRN) which has not been tested so far. IIGP1 could be immunoprecipitated with  165 serum, as 
well as with monoclonal antibodies. Co-precipitation of three putative proteins was acheived, but 
the identity of these molecules remains to be unknown. 
 
IIGP1 is a monomer in the nucleotide-free state in solution, and also in the presence of GDP, but 
cyrstallised as a dimer with or without GDP. In the presence of nucleotide triphosphates, IIGP1 
forms higher oligomers. The importance of the dimer on the properties of IIGP1 was investigated 
by interfering with the dimer interfaces. The interface mutants have no defects in nucleotide 
binding but have abrogated cooperativity unlike the wild type, suggesting the functional importance 
of the dimer. However, the oligomerisation properties of the interface mutants has not been 
analysed.  
 
The data described here formulates a platform for further analysis on IIGP1 function and provides 
essential parameters to understand the molecular mechanism by which IIGP1 participates in this 
complex resistance programme. The characterisation of IIGP1 gives an understanding to the 
behaviour and properties of the protein  and . 
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VIII. ZUSAMMENFASSUNG 
 
Die hier vorgelegte Arbeit befaßt sich mit der biochemischen, strukturellen und zellulären 
Charakterisierung der 47 kDa GTPase IIGP1.  
 
Die Familie der 47 kDa GTPasen wird durch Interferon auf Transkriptionsebene stark induziert und 
mit der zellautonomen Resistenz gegen intrazelluläre Pathogene in Verbindung gebracht. Eine 
große Anzahl von Genen wird durch Interferone induziert aber nur für wenige dieser Gene sind 
mechanistische Details bekannt. Deshalb schien es notwendig die Funktion der 47 kDa GTPasen 
näher zu untersuchen. IIGP1 ist als Mitglied dieser Familie das Objekt dieser Studie. IIGP1 wurde 
in *  exprimiert, hoch aufgereinigt und biochemisch untersucht. IIGP1 ist eine GTPase mit 
niedriger Affinität für Nukleotide und niedriger GTPase Aktivität. Darüber hinaus ist die GTPase 
Aktivität konzentrationsabhängig und es findet eine nukleotidabhängige, funktionelle Interaktion 
zwischen IIGP1 Molekülen statt. Wie die 67 kDa GTPase hGBP-1 (durch Typ I und Typ II 
Interferon induziert), die antiviralen Mx Proteine (durch Typ I Interferon induziert) und die großen, 
selbstaktivierenden Dynamine weist IIGP1 eine mikromolare Affinität zu Nukleotiden und eine 
oligomerisationsabhängige Hydrolyseaktivität auf. IIGP1 unterscheidet sich jedoch von den 
aufgeführten Proteinen durch den Befund, daß seine Affinität zu GDP höher ist als zu GTP. 
 
Die Kristallstruktur zeigt, daß IIGP1 aus 3 strukturellen Domänen besteht. Auf die N-terminale 
helikalen Domäne, folgt eine GTP-Bindungsdomäne, die strukturell auch bei anderen GTP-
bindenden Proteinen zu finden ist. Die C-terminale Domäne weist wie der N-Terminus des Proteins 
eine helikale Struktur auf. Primär- und Sekundärstruktuanalysen lassen den Schluss zu, daß die 
Kristallstruktur von IIGP1 representativ für alle 47 kDa GTPasen ist. Die geringe 
Sequenzhomologie an N- und C-Terminus könnte jedoch die nicht-redundante Funktion und 
unterschiedliche subzelluläre Lokalisierung der 47 kDa GTPasen erklären. 
 
Zelluläre Studien von IIGP1 wurden durchgeführt um die Eigenschaften und Funktion des Proteins 
näher zu untersuchen. Vorhergehende Untersuchungen ergaben, daß IIGP1 mit dem 
Endoplasmatischen Retikulum assoziiert ist. Da die Sequenzanalyse keine Hinweise auf 
Signalsequenzen, ER-Retention- oder ER-Zurückgewinnungs-Signale ergab, scheint IIGP1 peripher 
an die ER Membran gebunden zu sein. Der größte Teil des Proteins ist membrangebunden und nur 
ein kleinerer Teil ist löslich. Die Membranbindung ist teilweise von der Myristoylierung von IIGP1 
abhängig. Es gibt zudem Hinweise auf ionische Wechselwirkungen, welche die Assoziation des 
Proteins mit der Membran vermitteln könnten. Eine weitere Population bindet unabhängig von der 
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Myristoylierung und ionischen Wechselwirkungen an die Membran. Dies könnte durch das C-
terminale CaaX-ähnliche Motiv vermittelt werden. Um Interaktionspartner von IIGP1 zu 
indentifizieren wurden Immunpräzipitationen mit dem anti-IIGP spezifischen 165 Antiserum 
durchgeführt. Diese Untersuchungen ergaben drei coisolierte Proteine. Die genaue Identifizierung 
dieser möglichen Interaktionspartner steht jedoch noch aus. 
 
IIGP1 liegt in Lösung im nukleotidfreien und im GDP gebundenen Zustand als Monomer vor, 
kristallisierte jedoch unter beiden Bedingungen als Dimer. In Anwesenheit von GTP befindet sich 
IIGP1 in hocholigomerer Form. Die Eigenschaften der Dimerisierung von IIGP1 wurden durch 
Einsatz von gezielten Mutationen analysiert. Diese Mutanten zeigen keine Änderung der 
Nukleotidbindung, besitzen jedoch im Gegensatz zum Wildtyp einen Defekt in der funktionalen 
Kooperativität. Dies weist stark auf eine funktionelle Bedeutung des Dimers hin. 
  
Die hier vorgestellten Untersuchungen vermitteln einen Einblick in die molekularen Eigenschaften 
von IIGP1 und bilden die Grundlage für weitere Analysen zur Funktion von IIGP1, an deren Ende 
letztendlich die Aufklärung des funktionellen Beitrags von IIGP1 bei der zellautonomen Abwehr 
von Pathogenen stehen könnte. 
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